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Abstract 
 
 
Bacterial lipoproteins play important roles in prokaryotic physiology, protein 
transport, membrane biogenesis, and pathogenesis. Produced in the cytoplasm, these 
proteins are N-terminally modified by the covalent addition of a fatty-acid moiety 
onto a conserved cysteine residue. This acylation step allows for anchoring of the 
protein into a lipid bilayer in the absence of membrane-spanning domains. 
Lipoproteins of Borrelia burgdorferi, the etiologic agent of Lyme disease, are of 
particular interest because of their presence on the bacterial cell surface at the 
interface between pathogen and potential host. In Borrelia, lipoproteins must cross 
both an inner and outer membrane en route to the cell surface. In Escherichia coli, the 
process of transporting lipoproteins between two membranes has been extensively 
studied, but occurs only within the boundaries of the periplasmic space.  The 
mechanistic underpinnings of this process in Borrelia are not understood. Here, we 
provide the first insights into lipoprotein transport to the surface of the B. burgdorferi 
cell. 
Using fusions of a red fluorescent reporter protein to the B. burgdorferi surface 
lipoprotein OspA, we show that the sorting rules of E. coli do not apply but that 
information encoded within the first five residues of the mature lipoprotein is capable 
of directing proteins to the Borrelia cell surface. Negatively-charged residues within a 
certain context can result in the retention of a lipoprotein in the inner membrane. 
Extensive primary sequence mutagenesis of the OspA N-terminus revealed that, in 
 xi 
contrast to E. coli, the lipoproteins produced in Borrelia are localized to the surface of 
the cell by a default mechanism.  
Analysis of the lipoprotein N-terminus revealed that it has a propensity for disorder, 
rich in residues that are not conducive to the formation of protein secondary structure. 
We term this region the lipoprotein ‘tether’ and show that removal of individual 
residues from within the OspA tether does not prevent transport of the lipoprotein 
across the periplasmic space but is detrimental to translocation of the lipoprotein 
across the outer membrane. We show that in addition to the surface, B. burgdorferi 
lipoproteins are also native to the periplasmic leaflets of the inner and outer 
membranes. This demonstrates the existence of an accurate system for localization of 
lipoproteins within the Borrelia cell envelope and we propose a two-step model for 
their transport to the cell surface. The work performed herein will serve as the basis 
for further analysis into the process of protein transport and pathogenesis for an 
important human pathogen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Chapter I. Introduction 
 
Stemming from the 1969 discovery and first description of murein lipoprotein by 
Volkmar Braun and colleagues, bacterial lipoproteins are now known to be numerous 
and shown to have wide variety of important functions (Braun,1969). Synthesized in 
the cytoplasm, all lipoproteins contain a cleavable signal sequence that directs them 
through the cytoplasmic membrane (Pugsley,1993). At this point, the covalent 
addition of a lipid tail provides the protein with membrane-associable characteristics 
that are ideal for cellular compartmentalization. Identified in all bacterial genomes to 
date, some organisms are estimated to encode for over 100 lipoproteins by 
themselves, some with important physiological roles but many of purely hypothetical 
function (Fraser,1997;Tjalsma,1999). In some bacteria, such as the Lyme disease 
spirochete Borrelia burgdorferi, lipoproteins are doubly important due to their roles 
in the establishment of infection 
(Brandt,1990;Probert,1998;Pal,2000;Pal,2004;Kraiczy,2004;Ramamoorthi,2005; 
Revel,2005). In bacteria with more than one membrane (i.e. Gram-negatives and 
others such as the Borrelia spp.), it is critical that a mechanism exists for proper 
localization of lipoproteins within the cell envelope. Much work on lipoprotein 
sorting has focused on transport within the periplasm of Escherichia coli. Almost 
nothing is known regarding the exposure of lipoproteins on the surface of Borrelia 
burgdorferi. The work contained herein represents an effort to understand this 
important process in a pathogen of increasing relevance. 
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Lipoprotein Biogenesis 
Lipoproteins, like all other bacterial proteins, are first synthesized in the cytoplasm. A 
signal sequence (signal II peptide) is located at their amino-terminal end that 
specifically directs the prolipoprotein to the Sec translocon embedded in the 
cytoplasmic membrane (CM) (von Heijne,1989). The signal II peptide is 
characterized by the typical tripartite componentry of an amino-terminal positively-
charged (N) domain, hydrophobic (H) core, and cleavage (C) region. Only the C-
region differs significantly between lipoproteins and non-lipoproteins. In lipoproteins, 
the C-region is apolar and contains a consensus sequence of L-3(A/S)-2(G/A)-1↓C+1 
(von Heijne,1989). Though more recent studies have demonstrated degeneracy for the 
residues within the -3 to -1 positions, the cysteine residue following the cleavage site 
(Cys+1) is invariant and absolutely necessary for the proper maturation of a 
lipoprotein (Nakai,1999;Falquet,2002;Sutcliffe,2002;Juncker,2003). 
 
Following recognition by and passage of the prolipoprotein through the Sec 
apparatus, it undergoes a series of post-translational modifications that vary by 
bacterium but ultimately result in an N-terminally lipidated end product. In Gram-
negative bacteria, a trio of CM-bound enzymes catalyze the formation of the mature 
lipoprotein (Fig. 1). Lgt (lipoprotein diacylglyceryl transferase) transfers an sn-1,2-
diacylglycerl group from phosphatidylglycerol (PG) to the sulfhydryl group of the 
cysteine at position +1 via a thioether linkage 
(Chattopadhyay,1977;Tokunaga,1982;Gan,1993;Sankaran,1994). Lipoprotein signal  
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Figure 1.  Diagram of lipoprotein biogenesis in a typical Gram-negative 
organism. This figure shows the traditional steps taken in the maturation process of a 
lipoprotein. The positively-charged N region, hydrophobic core (H), and lipobox 
cleavage site (C) are labeled. Refer to text for details.
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peptidase (Lsp) specifically recognizes the glyceride-modified prolipoprotein and 
subsequently cleaves the signal peptide such that the amino-terminus of the newly-
formed apolipoprotein is a diglycerylcysteine residue 
(Tokunaga,1982;Yamada,1984). Lipoprotein N-acyl transferase (Lnt) performs the 
final step by removing an N-acyl group from membrane phospholipids (typically PG, 
but occasionally phosphatidylethanolamine (PE) and cardiolipin (CL)) and 
subsequently transferring it to the free amino group on the apolipoprotein’s N-
terminal diglycerylcysteine (Gupta,1991;Vidal-Ingigliardi,2007). The end result of 
these modifications is a triacylated protein localized to the outer leaflet of the 
cytoplasmic membrane. 
 
Variations in this three-step process exist, especially amongst Gram-positive 
organisms. Although biochemical analyses have shown lipoproteins of Bacillus 
subtilis and Staphylococcus aureus to be N-acylated, homologues of the lnt gene are 
conspicuously absent (Hayashi,1985;Navarre,1996;Tjalsma,1999). Conversely, 
Mycobacterium tuberculosis, Streptomyces coelicolor, and Corynebacterium 
glutamicum all seem to have copies of lnt, yet N-acylation of lipoproteins in these 
organisms has yet to be conclusively demonstrated (Vidal-Ingigliardi,2007). The 
mycobacterial Lnt occurs together with a polyprenol monophosphomannose synthase 
(PPM synthase) as part of a two-domain protein (Rv2051c) (Gurcha,2002). It has 
been suggested that the Lnt domain in Rv2051c may have a more important role in 
the bioysnthesis of lipoarabinomannan and lipomannan, two key components of the 
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unique mycobacterial cell wall, than in lipoprotein biogenesis 
(Rezwan,2007;Hutchings,2008). An attempt at the complementation of an E. coli 
conditional lnt mutant with homologues found in the Gram-positive bacteria S. 
coelicolor and C. glutamicum was unsuccessful. The use of lnt from the Gram-
negative bacteria Yersinia tuberculosis, Neisseria meningitidis, Vibrio cholerae, and 
Pseudomonas aeruginosa, however, did allow for growth of the E. coli mutant 
(Vidal-Ingigliardi,2007). These results suggest that N-acylation is more conserved 
and may play a more important role in lipoproteins of organisms containing more 
than one cell membrane. Supporting this idea are the findings that many Gram-
positive organisms contain only diacylated lipoproteins and that they are able to 
tolerate knockouts of genes encoding all three enzymes (lgt, lsp, and lnt) involved in 
lipoprotein biogenesis (Leskela,1999;Petit,2001;Reglier-Poupet,2003; 
Baumgartner,2007). This is quite the opposite from Gram-negative organisms, for 
which each of the three appear to be universally essential 
(Yamagata,1982;Gan,1993;Gupta,1993;Sankaran,1994;Robichon,2005). 
 
Differences in biosynthetic pathways extend prior to the lipid modification as some 
lipoproteins appear to use variations on traditional Sec-mediated export. The dimethyl 
sulfoxide reductase lipoprotein (DmsA) of the Gram-negative Shewanella oneidensis 
contains a twin-arginine transport (Tat) signal within its N-terminus and has been 
shown to pass through the inner membrane of this organism together with its partner 
DmsB (Gralnick,2006). DmsA is therefore transported in a completely folded Sec-
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independent fashion through the membrane (Lee,2006). Other lipoproteins have been 
demonstrated to use a less common SecA2-mediated mechanism of cytoplasmic 
membrane export. Very few proteins appear to require SecA2 versus the traditional 
SecA motor protein for transport across the CM. It is speculated that SecA2 may have 
a specialized role in the transport of factors related to Gram-positive pathogenesis 
(Lenz,2002;Braunstein,2003). Putative sugar uptake lipoproteins Msmeg1704 and 
Msmeg1712 of Mycobacterium smegmatis and two lipoproteins of unknown function 
in Listeria monocytogenes all appear to be dependent on the non-essential SecA2 for 
proper CM transport (Lenz,2003;Gibbons,2007).  
 
 
Diverse functions for bacterial lipoproteins 
The fatty acylation characteristic of all bacterial lipoproteins allows for sequestration 
in a membrane compartment. This is advantageous for the bacterium in that it can 
produce a protein and then tightly anchor it to its surface such that it isn’t lost into the 
extracellular milieu. These surface-localized proteins can have functions related to 
adhesion, enzymatic activity, and immune evasion. Alternatively, if the protein is 
required as part of a multi-subunit complex, lipoproteins can shuttle components 
between membranes or act as key stabilization proteins anchored in the membrane to 
assist in the coordinated construction of large periplasm-spanning transport 
machinery. 
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Lipoproteins have important structural functions in bacteria. The well-characterized 
Braun’s lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are critical 
to maintenance of membrane integrity in Escherichia coli. The absence of either of 
these two proteins results in the sloughing off of membrane vesicles, leakage of 
periplasmic contents, and increased drug sensitivity due to improper linkage of the 
cell wall to the OM 
(Sonntag,1978;Lazzaroni,1981;Lazzaroni,1992;Bernadac,1998;Cascales,2002). 
MxiM is an OM pilotin lipoprotein of Shigella flexneri that aids in the assembly of 
the Type III Secretion (T3SS) needle apparatus. It functions to ensure the proper 
localization of MxiD subunits that oligomerize to form a ring-like OM secretin 
complex. True to its name, MxiM ‘pilots’ MxiD across the periplasm for specific 
insertion into the OM (Schuch,1999). Assembly of the MxiD secretin allows for 
downstream construction and secretion of important components through the T3S 
injectisome (Lario,2005;Okon,2008). A similar function has been attributed to the 
Klebsiella oxytoca pilotin PulS. In the absence of this lipoprotein, the PulD secretin is 
mislocalized in the inner membrane (Guilvout,2006). Tgl is a lipoprotein known to 
assist in the assembly of the Myxococcus xanthus secretin PilQ. Aside from PilQ 
assembly, Tgl may be unique in that it appears to also play a role in cell-cell 
communication through contact-dependent stimulation of secretin assembly 
(Nudleman,2005;Nudleman,2006). 
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The lipoproteins YfgL, NlpB, YfiO, and SmpA (BamB-E, respectively) of E. coli 
help stablize the structure of an important OM biogenesis complex, the 
YaeT/Omp85/BamA (β-barrel assembly machinery) complex 
(Voulhoux,2003;Wu,2005;Bos,2006;Malinverni,2006;Sklar,2007. The Bam complex 
is critical to the correct insertion of OM-spanning proteins, many of which are 
nutrient transporters of the bacterium. The importance of this process is demonstrated 
by the essentiality of YfiO/BamC and the fact that null mutants of the other three 
lipoproteins result in severe OM biogenesis defects due to permeabilization of the 
membrane (Wu,2005;Malinverni,2006;Sklar et al., 2007, Proc Natl Acad Sci U S A, 
104, 6400-5;Vuong,2008). 
 
Lipoproteins also play key roles in the virulence of certain pathogens. SphB1 is a 
surface-exposed lipoprotein of the whooping cough agent Bordetella pertussis. It is 
required for the enzymatic cleavage of filamentous hemagluttinin (FhaB), the major 
antigen of B. pertussis, into its mature form (Coutte,2001;Coutte,2003;Mazar,2006). 
Both MtrC and OmcA assist in the reduction of solid metal oxides in and are found 
on the surface of the bacterium Shewanella oneidensis (Shi,2008).NalP of Neisseria 
meningitidis is a proteolytic surface lipoprotein required for the proper maturation of 
two proteins, App (an adhesin expressed during human colonization) and IgA 
protease (van Ulsen,2001;van Ulsen,2003). SphB1, MtrC, OmcA, and NalP are rare 
amongst bacterial lipoproteins by virtue of their surface localization. The presence of 
lipoproteins on the cell exterior is not unusual for Gram-positive organisms due to 
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their single membrane. Most bacterial lipoproteins of Gram-negative organisms, 
however, are found within the confines of the periplasmic space. In addition to these 
four examples, the majority of lipoproteins from another pathogen, Borrelia 
burgdorferi, are also found on its cell surface. 
 
 
Borrelia burgdorferi and Lyme disease 
 
Borrelia burgdorferi is the pathogen responsible for Lyme disease in North America. 
Lyme disease is a nationally notifiable disease in the United States based on rising 
numbers of infections across North America and Europe. In the 15-year period 
between 1992 and 2006, nearly 250,000 cases of Lyme disease were reported to the 
Centers for Disease Control (CDC) (Bacon,2008). The classification of Lyme disease 
as an “emerging infectious disease” is perhaps misleading when one considers that 
symptoms arising from infection with borreliae have been detailed for quite some 
time and that physicians have been wrangling for the better part of 130 years to 
pinpoint the cause of its infectious sequelae. In 1883, the German physician Alfred 
Buchwald was the first to describe the symptoms of infection as a “diffuse idiopathic 
skin atrophy” (Buchwald,1883). This condition, with symptoms causing the skin to 
take on a thin, wrinkled “tissue-paper-like” appearance is now well understood to be a 
late-stage manifestation of European Lyme borreliosis (Steere,2001). In late October 
of 1909, at a meeting of the Swedish Dermatological Society, Arvid Afzelius 
presented data on a curious rash that tended to spread outward on the skin into a 
bullseye-like pattern. He referred to this condition as “erythema migrans (EM),” the 
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first usage of a term that is characteristic of and diagnostic for B. burgdorferi 
infections to this day (Afzelius,1910;Tibbles,2007). Afzelius later hypothesized that 
the rash might in some way be connected to the bite of a tick (Afzelius,1921). 
Meanwhile, in North America, Wisconsin physician Rudolph Scrimenti, who had 
been following Europe’s cases and reports of its rash of unknown origin, was 
presented with a case of EM and noted for the first time that he was able to 
successfully treat the patient with a regimen of penicillin antibiotics (Scrimenti,1970). 
This was the first clear indication that EM might be related to a bacterial infection 
and was also the first documented case of EM in North America. It was not until 
seven years later that an outbreak of juvenile rheumatoid arthritis struck the 
community of Old Lyme, Connecticut. Careful analysis of those cases led to the 
discovery of a previously unknown spirochete and the conclusive link five years later 
between the pathogen (B. burgdorferi) and so-called Lyme disease 
(Steere,1977;Burgdorfer,1982). 
 
The clinical presentation of Lyme disease is varied, making early diagnosis somewhat 
difficult. The single clear diagnostic sign of infection is the tell-tale EM/bulls-eye 
rash, though oftentimes it will go unnoticed by the patient (if it even appears in the 
first place – approximately twenty percent of infections do not result in the EM rash 
(Steere,2001)). Accompanying the rash may be numerous non-specific symptoms 
including, but not limited to: depression, headache, muscle pain, generalized malaise, 
fatigue, and arthralgia (Steere,1989;Steere,2001). If left untreated, the disease can 
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take a variety of courses. Involvement in the skin is very common, but there are key 
differences in disease progression for North American and European cases of 
infection. This is widely attributed to the fact that different genospecies of Borrelia 
are implicated on the two continents: B. afzelii, B. garinii, and B. burgdorferi in 
Europe and B. burgdorferi alone in North America (Steere,2001). Skin lesions are 
typically limited to a rapidly spreading EM rash in North America, whereas European 
Lyme borreliosis can additionally result in lymphocytoma or acrodermatitis chronica 
atrophicans (Nadelman,1998). Other manifestations of Lyme disease arise in the heart 
(Lyme carditis), the nervous system (neuroborreliosis), and frequently in the joints 
(Lyme arthritis) (Sigal,1995;Logigian,1990;Steere,2001). For the great majority of 
patients, Lyme borreliosis is a non-fatal but debilitating disease. Nearly ten percent of 
patients with Lyme arthritis report pain for a duration of greater than one year 
(Rees,1994). Diagnosed early enough, it is easily and consistently treatable with 
antibiotic therapy (Seltzer,2000;Steere,2001). Only a vanishingly small number of 
patients, typically those who experience an atrioventricular heart block due to Lyme 
carditis, die as a result of borrelial infection (Steere,1989). 
 
Physiology of B. burgdorferi 
Borrelia burgdorferi is a member of the order Spirochetales and belongs to the same 
family (Spirochetaceae) as Treponema pallidum, the agent of syphilis. Leptospira 
interrogans, the cause of leptospirosis, is a close relative from another family, the 
Leptospiraceae. Prior to the discovery of B. burgdorferi, spirochetes had been studied 
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for some time, dating back to the original description of the genus Spirochaeta by 
Christian Gottfried Ehrenberg in 1835 (Ehrenberg,1835). Syphilis, a disease known in 
literature to date from at least the fifteenth century, was not conclusively linked to T. 
pallidum until the early twentieth century (Noguchi,1912). The spirochetes are 
therefore both historically and evolutionarily an ancient phylum of the bacterial 
kingdom. This phylogenetic antiquity is manifest in a bacterial morphology and 
membrane architecture that are strikingly different from traditional Gram-positive and 
Gram-negative organisms.  
 
The dimensions of B. burgdorferi vary between 100nm and 300nm in width by 10µm 
and 25µm in length (Holt,1978;Goldstein,1996). This is dramatically different from 
bacteria such as the prototypical 0.5-1µm x 2µm rod-shaped E. coli: the narrow width 
of Borrelia falls below the wavelength of visible light and therefore precludes direct 
visualization of the organism by light microscopy. When viewed under phase contrast 
or darkfield microscopy, the flat waveform morphology unique to this phylum is 
clearly visible. The corkscrew-like shape greatly enhances the ability of spirochetes to 
traverse viscous media and burrow deep into tissues such as the connective tissue 
found within joints (Berg,1979;Goldstein,1994;Motaleb,2000;Nakamura,2006). The 
spiral shape is due in part to the presence of endoflagella anchored to each pole of the 
bacterium (axial filaments) (Holt,1978;Charon,2009). These unique flagella are 
entirely enclosed within the periplasmic space of the spirochete and have terminal 
motors operating in opposing directions to provide motility 
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(Charon,2002;Charon,2009). So important to spirochetal survival are its flagella that 
an estimated six percent (54 ORFs) of the B. burgdorferi genome is dedicated to 
genes involved in motility (Fraser,1997).Yet they are not the only unique 
characteristic of the Borrelia ultrastructure. Unlike Gram-negative organisms, which 
contain a thin peptidoglycan layer in close association with the OM, the cell wall of 
Borrelia seems to instead be more tightly associated with the IM (Holt,1978). Also 
unlike the OM of Gram-negatives is the complete absence of lipopolysaccharide from 
the outer leaflet (Takayama,1987). See Fig. 2 for an illustration of these unique 
characteristics. 
 
In addition to its membrane architecture, B. burgdorferi also has a genetic 
organization that is arguably one of the most complex in bacteria, even when 
compared to other members of its own family. The genome itself is highly segmented 
with a linear chromosome of less than 1Mb and numerous extrachromosomal circular 
and linear plasmids of varying sizes (Fraser,1997;Casjens,2000;Rosa,2005). With one 
exception, the >20 plasmids are dispensable for in vitro bacterial growth, though 
contributions of each to the relative pathogenicity of a given B. burgdorferi strain 
have been identified (Purser,2000;Labandeira-Rey,2001;Rosa,2005). A 26-kb circular 
plasmid (cp26) contains the essential resT telomere resolvase that aids in resolution of 
the hairpin ends of the linear chromosome and is present in all known strains of B. 
burgdorferi (Kobryn,2002;Byram,2004;Jewett,2007). The genome itself  
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Figure 2.  Comparison of Escherichia coli and Borrelia burgdorferi membrane 
architecture. This is a simplified representation of some of the major differences 
between the membrane organizations for the two organisms. Labels refer to: outer 
membrane (OM), inner membrane (IM), peptidoglycan (PG), flagella (FL), and 
lipopolysaccharide (LPS). Representative lipoproteins from each organism are shown, 
along with the first four residues of each mature sequence. Highlighted in red are the 
+2 position amino acids, known to be important for sorting in E. coli but not in 
Borrelia.
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is very A/T rich, with a G/C content of only 28.6% (Fraser,1997). Though not large in 
size, the genome does encode for a proportionally high number of lipoproteins, with 
nearly 10% dedicated to known or hypothetical lipoproteins (Fraser,1997). Many of 
these lipoproteins have no known homologues and it is thought that they may 
contribute to spirochete-specific mechanisms of pathogenicity. B. burgdorferi exists 
within an enzootic cycle together with its vectors, species of Ixodes ticks. This life 
cycle has now been well-characterized and shown to be heavily dependent on the 
correct trafficking of key lipoproteins to the bacterial cell surface. The bacterium is 
intimately associated together with its arthropod vector during a series of moltings 
and feedings. The lifespan of a typical Ixodes spp. tick is approximately two years 
and consists of three distinct stages: larval, nymphal, and adult 
(Fish,1995;LoGiudice,2003). Typically, entry of B. burgdorferi into the zoonotic 
cycle occurs upon the feeding of an infected mammalian reservoir (often the white-
footed mouse, Peromyscus leucopus) by the deer tick, Ixodes scapularis 
(Barbour,1993;LoGiudice,2003). The feeding process takes approximately four days 
and during this time, the bacterium is ingested by the tick (within 48 hours of feeding 
start) and establishes residency in the arthropod’s midgut (Piesman,1987). After 
completion of a bloodmeal, the tick will undergo the process of molting and move on 
to the nymphal stage. It is at this point that the tick, harboring the spirochete in its 
digestive tract, is at its most aggressive in feeding and consequently this is the stage at 
which transmission to humans frequently occurs (Wormser,2006). The nymphal tick 
will spend approximately one year in an adult stage, with the ability to transmit the  
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Figure 3.  Enzootic lifecycle of Borrelia burgdorferi and Ixodes spp. ticks. A 
simplification of the vector-host cycle in which B. burgdorferi takes part. The entire 
cycle of tick development (from egg to larva to nymph to adult) takes approximately 
two years. The tick is at its most aggressive during the unfed nymphal state; 
consequently this when most accidental transmissions of the spirochete to humans 
occur.
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disease upon each feeding. Reproduction leads to the female tick laying eggs and 
starting the cycle once again. There is no documented evidence of transovarial 
transmission as occurs in Ricketsia rickettsii, therefore the larval ticks must reacquire 
B. burgdorferi from a competent reservoir and thus the process continues 
(Schwan,2000).Because of the extreme environmental changes encountered as it 
passes from vertebrate reservoir to arthropod vector and back, there is a necessity for 
a mechanism to allow the bacterium to shield itself from clearance in each situation. 
Recent studies have clarified the means by which B. burgdorferi is able to accomplish 
this and the underlying solution appears to be centered around the presence of highly 
specialized surface lipoproteins, especially OspA and OspC.  
 
OspA  
The ospA gene is present on a 54-kilobase linear plasmid (lp54) and encodes for a 
polypeptide containing a signal-II peptidase cleavage site, required for lipidation of 
the cysteine residue at position 17 (lipo-Cys17) 
(Howe,1985;Bergstrom,1989;Brandt,1990).  The mature form of OspA (processed 
and lipidated) is a 28kDa (257 amino acid) lipoprotein with significant antiparallel β-
sheet structure and a single carboxy-terminal α-helix (Li,1997). The amino-terminal 
twelve residues do not appear in the crystal structure on the basis of their weak 
electron density and are presumed to be disordered (Li,1997). At the C-terminal end 
are two residues, Phe237 and Ile243 which are brought into close apposition upon 
folding of the OspA polypeptide (Pal,2000). These two residues are part of a 
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hydrophobic pocket that binds to a receptor found within the tick midgut. This 
receptor, TROSPA (tick receptor for OspA), is required for colonization of I. 
scapularis and undergoes a cycle of expression which closely mirrors that of 
spirochete presence in the tick’s digestive system (Pal,2000;Schwan,2000;Pal,2004). 
Upon infection of the tick, mRNA levels of TROSPA are seen to increase within the 
tick and are seen to decrease upon ingestion of the next bloodmeal, presumably 
facilitating the exit of OspA-expressing B. burgdorferi from the vector’s midgut 
(Pal,2004). The signal for decreasing TROSPA mRNA production is thought to be 
the temperature shift encountered upon feeding (a shift from approximately 34°C to 
37°C) (Pal,2004). This same temperature has also been shown by in vitro studies to 
cause B. burgdorferi to switch the dominant antigen on its cell surface from OspA to 
OspC (Schwan,2000). 
 
OspC 
OspC is a variably expressed 23kDa protein that has been shown to be important in 
the early phases of mammalian infection. Like OspA, the gene encoding this protein 
is located on an extrachromosmal plasmid. ospC is found, interestingly enough, on a 
26kb circular plasmid (cp26) that is stably maintained in all strains of B. burgdorferi 
(Schwan,2000;Pal,2004). This would seem to indicate that an extremely important 
function might be ascribed to the gene product. Despite the fact that OspC is one of 
the most highly expressed proteins in B. burgdorferi, its function is not as clearly 
understood as OspA. Following ingestion of a bloodmeal, B. burgdorferi undergoes a 
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rapid reorganization of its lipoprotein repertoire and exchanges the OspA, which 
previously coated the cell surface, with OspC. Accompanying this change, the 
spirochete detaches from its receptor in the tick midgut and migrates to the salivary 
glands (Pal,2004;Grimm,2004;Liang,2004). A study using an ospC knockout strain of 
B. burgdorferi showed that this mutant was unable to bind to I. scapularis salivary 
gland tissue. Complementation of the missing gene with a copy introduced on an 
extrachromosomal plasmid restored binding to the salivary glands at levels equivalent 
to the wild-type strain (Pal, 2004). A protein produced by the tick, Salp15, is known 
to inhibit T-cell inactivation and was recently demonstrated to bind tightly to OspC 
while the spirochete migrated through the tick’s salivary glands. This finding may 
shed light on the role for OspC in promoting early stages of mammalian infection, as 
borreliae migrating from the tick may be shrouded in Salp15 
(Ramamoorthi,2005;Hovius,2008). 
 
Once transmission of the spirochete to the host is complete, later requirements for 
OspC remain poorly understood. One study showed that complementation of an ospC 
knockout strain with an unstable copy of ospC had no effect on the ability of the 
spirochete to infect naïve mice. Spirochetes recovered from the infected mice did not 
contain the plasmid-encoded ospC. This result suggests that OspC is only critical for 
very early stages of mammalian acclimatization and that the presence of this protein 
at later stages is unnecessary for infection to proceed (Tilly,2006). Another study 
used an ospC knockout strain grown inside an immunologically privileged peritoneal 
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dialysis chamber that had been implanted into rats. The spirochetes showed no 
difference from wild-type or complemented strains in their ability to grow and adapt 
inside the chamber (Stewart,2006). Though this shows that OspC is not required for 
spirochete survival inside the mammalian host, it does not clarify whether a 
physiological function for the protein exists, such as complement evasion (Stewart, 
2006). Intradermal injection of ospC - spirochetes into C3H-HeN mice were cleared 
rapidly (within 24h) whereas wild-type B. burgdorferi was isolated at all subsequent 
time points and from distal locations, indicating that OspC does seem to play a role in 
the early stages of mammalian infection (Tilly,2007). It is likely that this lipoprotein 
plays no role in protection from the adaptive immune response as it is typically not 
expressed by the bacterium for a period of time that is long enough to be targeted by 
antibodies. In fact, constitutive expression of ospC has been shown to be detrimental 
to spirochete survival in immunocompetent mammals (Xu,2006). 
 
 
Protein trafficking in bacteria 
 
The presence of OspA and OspC on the surface of B. burgdorferi illustrates a solution 
to a classic problem faced by bacteria, namely how to transport a protein produced in 
the cytoplasm through multiple lipid bilayers to the cell surface or beyond. Numerous 
mechanisms have been devised by bacteria for just this purpose, occasionally 
encoding complex systems dedicated in some cases to the transport of only a single 
known protein (Odenbreit,2000;Driessen,2001;Pugsley,2004;Economou,2006). 
Pathogens are especially well-equipped to selectively secrete key proteins into their 
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surroundings that promote their survival in different ways. Toxins, adhesins, and 
proteases are just a few of the various types of secreted proteins seen in bacteria, and 
many of them are transported with the help of dedicated mechanisms that have 
evolved to allow for transport to occur precisely when required by the bacterium for a 
given condition (Galan,1999;Durand,2005;Mougous,2007). There are thought to exist 
several so-called “secretion systems” that are all unique in their compositions and 
mechanisms of action but similar in that they all function to move a given protein 
from the cytoplasm to the surface of the cell or beyond. At least seven different types 
of secretion systems (Type 1 to Type 7 Secretion System, T1SS  T7SS) have been 
described in the literature (For reviews on these systems, see Henderson,2004; 
Christie,2005;Holland,2005;Economou,2006;Johnson,2006;Mougous,2006;Putkatzki,
2006;Cornelis,2006;Abdallah,2007).  
 
Of the seven types of secretion systems, there are three (T2SS, T4SS, and T5SS) that 
are wholly (T2SS, T5SS) or partly (T4SS) dependent on the proper function of the 
Sec/Tat translocation machinery for the early steps in the movement of a given 
protein to the cell exterior (Economou,2006). The primary role for the Sec/Tat 
systems is to move a polypeptide across the cytoplasmic membrane 
(Driessen,2001;Ize,2002;Pugsley,2004). For Gram-positive organisms, this is 
equivalent to moving a protein to the cell surface. For Gram-negative bacteria, the 
proteins enter the periplasmic space. The Sec system is the predominant mechanism 
by which proteins are moved across the cytoplasmic membrane in both Gram-positive 
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and Gram-negative organisms. The Sec machinery consists of a membrane-bound 
SecYEG complex which functions as a pore through which polypeptides are funneled 
(van den Berg,2004;Luirink,2005;Papanikou,2007). ATP hydrolysis provided by the 
SecA motor protein provides the energy necessary to ratchet the unfolded protein 
through the membrane (Zimmer,2008;Erlandson et al., 2008, J Biol Chem, 283, 
15709-15;Erlandson et al., 2008, Nature, 455, 984-7). The nascent protein can then 
either be inserted laterally into the cytoplasmic membrane by the actions of YidC or 
is otherwise released into the periplasm for further transport or function 
(Luirink,2005;Xie,2008). Another mechanism, the Tat system, relies on the presence 
of a special twin-arginine motif present in the N-terminal signal peptide that directs 
the protein to a special complex designed for the transport of folded proteins across 
the CM (Thomas,2001;Ize,2002;Lee,2006;Tullman-Ercek,2007). Other systems 
(T1SS, T3SS, T4SS, T6SS, T7SS) are organized in such a fashion that transport of 
the protein across the cytoplasmic membrane bypasses the Sec machinery altogether. 
Foremost among these mechanisms is the well-characterized Type 3 Secretion 
System (T3SS). Used by pathogens such as Yersinia pestis (plague), Salmonella 
typhimurium (gastroenteritis), Shigella flexneri (bacillary dysentery), and Bordetella 
pertussis (whooping cough), the characteristic needle complex (injectisome) has the 
ability to directly transfer effector proteins into the host cell cytosol (Cornelis,2006). 
 
Outer-membrane specific proteins that are to be inserted into the membrane, but not 
secreted are carried across the periplasm of Gram-negative bacteria via the Skp and 
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SurA chaperones (Bos,2006). Skp and Sur aid in the process of taking OM proteins 
from the Sec system and directing them to the OM protein assembly complex known 
as the Bam complex (B-barrel assembly machinery) (Sklar et al., 2007, Genes Dev, 
21, 2473-84). Interaction of the C-termini of OMPs with the N-terminal POTRA 
domains of the BamA protein result in the folding and membrane insertion of the 
OMP (Voulhoux,2003;Bos,2006;Robert,2006;Kim,2007;Gatzeva-Topalova,2008). 
 
 
Lipoprotein transport 
Many Gram-negative lipoproteins have no transmembrane domains and are sorted to 
and inserted into the OM by a different process. Lipoproteins appear to use a 
combination of the Sec machinery and a dedicated transport system, the Lol system 
for lipoprotein localization (Narita,2004;Tokuda,2004). The Lol pathway was 
originally worked out experimentally in E. coli but has since been shown to likely be 
a near-universal system for proper localization of lipoproteins in organisms with more 
than one membrane (diderms). The prototypical Lol machinery is made up of five 
components, an ABC-like transporter, LolCDE, a periplasmic chaperone, LolA, and 
an OM receptor, LolB (Matsuyama,1995;Matsuyama,1997;Yakushi,2000).  
 
After the lipoprotein exits the Sec translocon and is modified by the action of Lgt, 
Lsp, and Lnt, the process of localization occurs. The sorting of a lipoprotein in E. coli 
and other species of the family Enterobacteriaceae seems to be heavily influenced by  
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Figure 4. Lol-system-mediated lipoprotein transport to the E. coli outer 
membrane. Transport of a lipoprotein from the cytoplasmic membrane to the inner 
leaflet of the outer membrane requires a five-component system named Lol. A 
lipoprotein bound for the OM is first recognized by an ABC-transporter-like complex 
(LolCDE) in the IM. The lipoprotein is passed off to a periplasmic chaperone (LolA) 
in a 1:1 water-soluble complex. The affinity of the outer membrane receptor (LolB) 
for the acylated moiety of the lipoprotein is very high; it receives the lipoprotein and 
inserts it into the periplasmic face of the OM.
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the identity of the residue immediately adjacent to the fatty-acylated N-terminal 
cysteine (Tokuda,2004;Lewenza,2006). An aspartic acid residue at this ‘+2’ position 
is sufficient to cause lipoprotein retention in the cytoplasmic membrane 
(Yamaguchi,1988;Gennity,1991. Most other +2 residues support recognition by  
LolCDE and are sorted to the OM, where they are inserted by the OM receptor, LolB. 
The basis for Asp+2 retention seems to be a result of an inability to interact with the 
LolCDE complex and therefore may be a passive avoidance mechanism rather than 
active retention. It has been proposed that the negative charge of the residue is 
necessary but not sufficient for retention as a Glu+2 signal does not result in IM 
localization (Terada,2001). Hara et al. showed that the interatomic distance between 
the Cα and negative charge of the Asp side chain (2.72 – 3.69Å) is critical to IM 
localization of the lipoprotein (Hara,2003). In addition, a role for the positively-
charged phosphatidylethanolamine (PE) head group was proposed on the basis of the 
observation that Asp+2 no longer functioned as a retention signal when PE had been 
treated with sulfo-N-hydroxysuccinimide acetate, an amine-specific reagent 
(Hara,2003). 
 
Certainly Asp+2 may be a potent lipoprotein IM retention signal, but it has been 
clearly demonstrated that it is not the only residue that results in LolCDE avoidance. 
Using a lipidated variant of the E. coli maltose binding protein MalE, Seydel et al. 
convincingly showed that Phe, Pro, Trp, and Tyr were just as effective in retaining 
the reporter lipoprotein in the IM (Seydel,1999). Though these four residues might be 
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effective as retention signals, they are not found at the +2 position of any known E. 
coli lipoproteins. The strength of the avoidance signal has the potential to be 
weakened if Ala, Cys, His, Ile, Lys, or Thr are present at the +3 position. Conversely, 
when not present at the +2 position, Asp+3 appears to be equally, if not more effective 
provided the residue at position +2 is Asp, Glu, Gln, or Asn (Tokuda,2004). 
Ambiguity exists for other residues, such as Gly+2, which seems to localize 
lipoproteins to both membranes regardless of whether Asp is at the second 
position(Seydel,1999).  These findings suggest that there be the potential for fine-
tuning of lipoprotein localization in E. coli and that the process of lipoprotein sorting 
may not be a strictly OM/IM binary decision.  
 
Outside of the Enterobacteriaceae, very little is understood about the signals that 
govern lipoprotein sorting. Work in Pseudomonas aeruginosa suggests that the 
residues at the +3 and +4 positions may hold more importance to localization in that 
organism (Narita,2007). Other organisms seem to contain an incomplete set of the Lol 
proteins. Neisseria gonorrhoeae, Bordetella pertussis, and Geobacter sulfurreducens 
are apparently missing a copy of LolE. Desulfovibrio vulgaris and Brucella suis are 
additionally missing a copy of the OM LolB receptor (Narita,2006). Homologues for 
LolA and LolCDE have been identified in Borrelia burgdorferi but no LolB 
homologue has been found. As no information currently exists for the process of 
sorting lipoproteins in B. burgdorferi, the work presented here represents the first true 
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steps in identifying the basis for localization of the important lipoprotein virulence 
factors for this organism. 
 
The experiments performed in this body of work are geared to the identification of the 
basic underlying tenets of lipoprotein sorting in B. burgdorferi. Chapter II presents 
first insights into the sequence-specific rules governing membrane localization of 
lipoproteins and reveals that B. burgdorferi may possess a default mechanism for 
lipoprotein transport to its cell surface. We introduce the possibility that inner-
membrane retention of lipoproteins may also be governed by the presence of 
negatively-charged residues, but only in an appropriate context. Chapter III expands 
on this knowledge by further analyzing the unstructured region at the N-terminus of 
bacterial lipoproteins and presenting evidence that it plays a role in regulation of OM 
translocation. This role, in contrast to regulation of IM release, may be sequence-
independent in nature. Chapter IV examines the role of lipoproteins from subsurface 
compartments in Borrelia and introduces an assay that takes advantage of such 
lipoproteins to aid in the discovery of novel sorting signals. Chapter V uses epitope-
tagged mutants generated in the research from Chapter III for the purposes of making 
a first attempt at identifying components of a putative OM lipoprotein translocase. 
This research therefore represents a progression from first understanding the 
principles used to determine whether a lipoprotein is sorted to determining the 
mechanism by which the proteins are physically sorted. We present a final model 
based on our findings that suggests the existence of a two-step recognition process for 
lipoprotein secretion to the cell surface. Together, the data gathered here will serve as 
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a basis for more detailed examinations of lipoprotein transport in this important 
pathogen.  
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Chapter II: Borrelia burgdorferi Lipoproteins are Secreted to the Outer Surface 
by Default 
 
Abstract 
Borrelia spirochaetes are unique among diderm bacteria in their abundance of 
surface-displayed lipoproteins, some of which play important roles in the 
pathogenesis of Lyme disease and relapsing fever.  To identify the lipoprotein sorting 
signals in Borrelia burgdorferi, we generated chimeras between the outer surface 
lipoprotein OspA, the periplasmic oligopeptide-binding lipoprotein OppAIV and 
mRFP1, a monomeric red fluorescent reporter protein.  Localization of OspA and 
OppAIV point mutants showed that Borrelia lipoproteins do not follow the “+2” 
sorting rule which targets lipoproteins to the cytoplasmic or outer membrane of gram 
negative bacteria via the Lol pathway.  Fusions of mRFP1 to short N-terminal 
lipopeptides of OspA, and surprisingly OppAIV, were targeted to the spirochaetal 
surface.  Mutagenesis of the OspA N-terminus defined less than five N-terminal 
amino acids as the minimal secretion-facilitating signal.  With the exception of 
negative charges, which can act as partial subsurface retention signals in certain 
peptide contexts, lipoprotein secretion occurs independent of N-terminal sequence.  
Together, these data indicate that Borrelia lipoproteins are targeted to the bacterial 
surface by default, but can be retained in the periplasm by sequence-specific signals. 
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Introduction 
Throughout their vector-host lifecycle, Borrelia spirochaetes causing tick-borne 
Lyme borreliosis and relapsing fever display abundant surface lipoproteins, which are 
anchored in the bacterial outer membrane lipid bilayer via an N-terminal triacyl-
modified cysteine (Brandt,1990;Beermann,2000).  Some of these lipoproteins are 
important virulence factors during transmission, colonization and persistence of these 
bacterial pathogens.  For example, the outer surface protein A (OspA) of the Lyme 
borreliosis agent Borrelia burgdorferi (Howe,1985) is involved in bacterial 
colonization of the tick midgut (Pal et al., 2000; Pal et al., 2001; Pal et al., 2004) and 
has been used as a first-generation, transmission-blocking Lyme disease vaccine for 
humans (Steere et al., 1998).  In contrast, OspC is upregulated during tick feeding and 
involved in establishing mammalian infection (Schwan and Piesman, 2000; Gilmore 
and Piesman, 2000;Pal et al., 2004;Grimm et al., 2004;Ramamoorthi et al., 2005).  
The variable large (Vlp) and small (Vsp) proteins of relapsing fever agents such as 
Borrelia hermsii or Borrelia turicatae are immunodominant and antigenically distinct 
lipoproteins, which allow the spirochaetes to repeatedly evade the host’s immune 
reponse by multiphasic antigenic variation and to target different tissues (Cadavid et 
al., 2001; Barbour, 2003). 
 Despite the obvious importance of surface lipoproteins for Borrelia 
pathogenesis, the sequence of molecular events leading from their cytoplasmic 
expression to their emergence on the bacterial surface as biologically active 
molecules remains largely unknown.  We recently showed that recombinant B. 
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burgdorferi can express and present on their surface biologically active relapsing 
fever Borrelia Vsps and Vlps (Zückert et al., 2004).  This demonstrated that the 
lipoprotein transport machineries in the genus Borrelia are functionally conserved.  
Detailed studies on lipoprotein secretion in other diderm, i.e. double-membrane 
bacteria (Gupta, 1998) have been limited to a few model proteins, which are 
transported by either a type II or an autotransporter secretion pathway (Pugsley, 
1993;Coutte et al., 2003;van Ulsen et al., 2003).  Yet, homologs of a type II secretion 
apparatus, other Sec-dependent or –independent secretion pathways are absent from 
the B. burgdorferi genome (Fraser et al., 1997;Casjens et al., 2000;Haake, 2000), and 
known surface Borrelia lipoproteins do not contain C-terminal structural features of 
autotransporter translocator domains (Oomen et al., 2004). 
 Based on the identification of Lol homologs in B. burgdorferi (Masuda et al., 
2002), we previously suggested that Borrelia spirochetes instead use a Lol-like 
system to transport lipoproteins (Zückert et al., 2004).  The Escherichia coli Lol 
pathway sorts major lipoproteins such as Braun’s lipoprotein Lpp (Braun and Rehn, 
1969) to the periplasmic leaflet of the outer membrane (OM) via the Lol pathway 
(Tokuda and Matsuyama, 2004).  Lipoprotein sorting within the periplasm is based on 
the properties of the amino acid following the N-terminal, acylated Cys, i.e. the so 
called ‘+2 rule’, with Asp serving as the canonical inner membrane (IM) retention 
signal (Yamaguchi et al., 1988).  Pro or aromatic amino acids Phe, Trp, Tyr can also 
act as retention signals (Seydel et al., 1999).  On the other hand, Ser or other amino 
acids at the same position act as OM signals.  Amino acids at position +3 can either 
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weaken (Lys) or strengthen (Asp, Glu, Gln, Asn, Arg) IM retention by avoiding 
interaction with the Lol system (Masuda et al., 2002; Terada et al., 2001).  However, 
mislocalization of B. burgdorferi surface lipoproteins to the E. coli IM and the 
analysis of primary sequences of spirochaetal lipoproteins (Dunn et al., 1990; Haake, 
2000) suggested that sorting signals are different from those found in other diderm, 
i.e. double-membrane bacteria (Gupta, 1998). 
 In this study, we used fusions of amino terminal lipopeptides to a monomeric 
red-fluorescent reporter protein to visualize lipoproteins in the periplasm and on the 
surface of living spirochaetes.  This allowed us to determine readily the cellular 
localization of B. burgdorferi surface and sub-surface lipoprotein mutants, granting 
the first intriguing insights into the molecular mechanisms of spirochaetal lipoprotein 
targeting. 
 
Results 
B. burgdorferi Lipoprotein Sorting Does Not Follow the ‘+2 Rule’.  The linear 
chromosome and numerous linear and circular plasmids of B. burgdorferi harbour 
genes for more than 130 potential lipoproteins (Casjens et al., 2000; Fraser et al., 
1997).  Our sequence analysis of 31 known lipoproteins indicated that the sorting 
rules for E. coli lipoproteins cannot be applied to predict the actual localization of B. 
burgdorferi lipoproteins.  While over 75% of these lipoproteins have “OM-
permitting” Lys or Asn residues at position +2, at least two known surface-exposed 
lipoproteins, the fibronectin-binding BBK32 (Probert and Johnson, 1998) and P27 
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(Reindl et al., 1993) have an “IM-retaining” Asp at this position.  A simple prediction 
of other amino acids serving as borrelial retention signals failed as well: the 
oligopeptide-binding lipoprotein OppAIV is localized to the periplasm (Bono et al., 
1998) and has a Val at position +2, but so does OspD, a described outer surface 
protein (Norris et al., 1992).  This led us to hypothesize that the sorting of borrelial 
lipoproteins is governed by different amino acid determinants, and we took an 
empirical and step-wise approach to identify these rules. 
 
As model surface and subsurface lipoproteins, we chose two lipoproteins with well-
documented cellular localization, OspA (Barbour et al., 1983) and OppAIV (Bono et 
al., 1998).  We initially focused on OspA and OppAIV differences in positions +2 to 
+4 and swapped the OspA tripeptide K18Q19N20 with the OppAIV sequence VNE in 
an attempt to mislocalize OspA (Figs 5 and 6).  A mutant ospA(VNE)18 gene was 
generated by sequence overlap extension (SOE) PCR of a pBSV2 PflaB-ospA construct 
and transformed into B. burgdorferi B313, which lacks lp54 and therefore its 
endogenous ospA copy (Sadziene et al., 1995).  Like wild type (w.t.) OspA, 
OspA(VNE)18 was susceptible to proteinase K treatment of intact cells, i.e. surface-
exposed, while the periplasmic FlaB protein was protected (Fig. 6).  A single +2 
residue mutant , OspAV18, behaved similarly (not shown).  This confirmed that even a 
modified ‘+2 rule’ does not apply to borrelial lipoproteins. 
 
 
 39 
Figure 5.  Amino-terminal sequences of B. burgdorferi lipoprotein mutants.  B. 
burgdorferi strains are indicated in the first, recombinant plasmids in the second 
column.  The lineage of mutated constructs is indicated by brackets to the left.  B. 
burgdorferi B31 OspA and OppAIV lipopeptide sequences starting with the Cys at 
position +1 are marked by solid or dotted underlining, respectively.  mRFP1 
sequences are not underlined.  Amino acid replacements are indicated in bold, 
deletions by a delta (Δ).  The protein nomenclature is identical throughout the text:  
numericals following OspA and OppAIV indicate the length of N-terminal 
propeptides, i.e. starting with fMet.  Mutants are designated in subscript by the 
introduced amino acid followed by their position in OspA and mRFP1, again with 
respect to the fMet.  Sets of multiple amino acid changes are summarized by the 
peptide sequence in brackets followed by the position of the first mutated residue.  
Protein phenotypes are summarized as follows: asterisks (*) indicate surface 
localization of the expressed protein (see Figs. 6, 7 and 10); a double-dagger (‡) 
indicates that OspA28(5A)18:mRFP1 is surface-exposed, but also forms protease-
resistant aggregates (see text and Fig. 10A); a section sign (§) indicates that OspAΔL24 
localizes predominantly to the inner leaflet of the OM (Figs. 6 and 9); and daggers (†) 
denote unstable or toxic proteins (see text).  
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KU-1038    pRJS1029  C K Q N V S S D E K N S V S V D L P G  OspA  L24
B31        pRJS0999  C K Q N V S S L D E K N S V S V D L P  OspAwt
KU-1009    pRJS1009  C K Q N V S S L D E K N A S S E D V I  OspA28:mRFP1
KU-1018    pRJS1012  C K Q N V S S L D A S S E D V I K E F  OspA25:mRFP1
KU-1019    pRJS1013  C K Q N V S A S S E D V I K E F M R F  OspA22:mRFP1
KU-1024    pRJS1015  C K Q N V A S S E D V I K E F M R F K  OspA21:mRFP1
KU-1025    pRJS1016  C K Q N A S S E D V I K E F M R F K V  OspA20:mRFP1 
KU-1020    pRJS1014  C K Q A S S E D V I K E F M R F K V R  OspA19:mRFP1
KU-1008    pRJS1009  C A S S E D V I K E F M R F K V R M E  OspA17:mRFP1
KU-1028    pRJS1019  C K Q A A A S L D E K N A S S E D V I  OspA28(3A)20:mRFP1
KU-1030    pRJS1021  C K Q N S S S L D E K N A S S E D V I  OspA28S21:mRFP1
KU-1034    pRJS1025  C K Q N E S S L D E K N A S S E D V I  OspA28E21:mRFP1
KU-1035    pRJS1026  C A A A A A S L D E K N A S S E D V I  OspA28(5A)18:mRFP1
KU-1036    pRJS1027  C K Q A A A A A A E K N A S S E D V I  OspA28(6A)20:mRFP1
KU-1037    pRJS1028  C K Q A A A S L D A A A A S S E D V I  OspA28(3A)20/26:mRFP1
KU-1032    pRJS1023  C K Q N A A A E D V I K E F M R F K V  OspA20:mRFP1(2A)3
KU-1033    pRJS1024  C K Q N A S S A A V I K E F M R F K V  OspA20:mRFP1(2A)5
KU-1040    pRJS1031  C K Q N A S S A D V I K E F M R F K V  OspA20:mRFP1A5
KU-1041    pRJS1032  C K Q N A S S E A V I K E F M R F K V  OspA20:mRFP1A6
B31        pRJS1000  C V N E S N R N K L V F K L N I G S E  OppAIVwt
KU-1039    pRJS1030  C K Q N V S S D E K N A S S E D V I K  OspA28 L24:mRFP1
KU-1043    pRJS1034  C K Q N V S S E D E K N A S S E D V I  OspA28E24:mRFP1
KU-1044    pRJS1035  C K Q N V E D L D E K N A S S E D V I  OspA28(ED)22:mRFP1
KU-1046    pRJS1037  C K Q N V S S E D V I K E F M R F K V  OspA20:mRFP1V2
KU-1027    pRJS1018  C K Q A A A S L D E K N S V S V D L P  OspA(3A)20
KU-1031    pRJS1022  C K Q N S S S L D E K N S V S V D L P  OspAS21
N/A        pRJS1033  C K Q N V S S E D E K N S V S V D L P  OspAE24               
N/A        pRJS1036  C K Q N V E D L D E K N S V S V D L P  OspA(ED)22
KU-1021    pRJS1004  C V N E V S S L D E K N S V S V D L P  OspA(VNE)18
KU-1010    pRJS1010  C V N E S N R N K L A S S E D V I K E  OppAIV31:mRFP1
KU-1029    pRJS1020  C V N E S S S L D E K N S V S V D L P  OspA(VNES)18
KU-1022    pRJS1005  C V Q N V S S L D E K N S V S V D L P  OspAV18
?
?
strain     plasmid   N-terminal peptide sequence            protein            phenotype
?
?
 *
 *
 *
 *
 *
 
 *
 *
 *
 *‡
 *
 *
 *
 *
 *
 *
 *
 *
 *
 *
 * 
 *§
 †
 †
 *
+1
KU-1052    pRJS1047  C S K M L A A L T R K T A S S E D V I  OspArandom:mRFP1
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Figure 6.  Localization of B. burgdorferi OspA mutants.  (A) Lipoprotein surface 
exposure was assessed by incubating intact B. burgdorferi B313 cells expressing 
OspA mutants from recombinant plasmids (see Fig. 5 and text) with proteinase K (pK 
+) or control buffer (pK –), followed by Western immunoblotting with antibodies 
against OspA and the periplasmic flagellar protein FlaB.  (B) Wild type and mutant 
OspA was localized by IFA microscopy of intact cells incubated with primary 
antibodies against OspA (w.t. surface control) and FlaB (periplasmic control) 
followed by a FITC-labelled secondary antibody.  Micrographs were taken under 
phase contrast (Ph) and epifluorescence (FITC). 
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Five N-terminal OspA Residues Mediate Lipoprotein Surface Localization.  
Crystallographic data of OspA, OspC, VlsE, BbCRASP1 and Vsp1 Borrelia surface 
lipoproteins showed that their N-termini are unordered and likely provide flexible 
lipopeptide tethers to the structural proteins (Li et al., 1997; Zückert et al., 2001; 
Eicken et al., 2001; Kumaran et al., 2001; Eicken et al., 2002; Cordes et al., 2005; 
Lawson et al.,2006).  We therefore expanded our search for Borrelia lipoprotein 
sorting signals from the +2 to +4 positions to span additional residues within these N-
terminal tethers.  To define the minimal targeting sequences while avoiding potential 
issues with mislocalized borrelial proteins, we generated fusions of N-terminal OspA 
lipopeptides to an inert reporter protein, monomeric red-fluorescent mRFP1 
(Campbell et al., 2002).  Our own preliminary studies (R.J. Schulze and W.R. 
Zückert, unpublished) as well as Chen et al. (Chen et al., 2005) showed that mRFP1, 
in contrast to green fluorescent protein (Feilmeier et al., 2000), is functional in the E. 
coli periplasm after Sec-dependent export.  In a contemporaneous study, mRFP1 was 
also successfully fused to ActA, a C-terminally anchored surface protein of the gram-
positive, monoderm Listeria monocytogenes (Rafelski and Theriot, 2005).  We 
therefore inferred that mRFP1 may be a suitable marker for periplasmic and surface 
compartments of B. burgdorferi. 
 We first fused two N-terminal OspA peptides to mRFP1 by SOE PCR, cloned 
the chimeric genes into pBSV2 under PflaB control and transformed B. burgdorferi 
B31-e2 cells.  OspA17:mRFP1 included only the type II signal sequence and lipobox 
of OspA up to Cys17, while OspA28:mRFP1 contained the OspA amino terminus up 
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to Asn28, the last residue not confined in β-sheet secondary structure (Li et al., 1997).  
Both fusion proteins were detectable under epifluorescence and by Western 
immunoblotting (Fig. 7).  Interestingly, the protein levels of OspA17:mRFP1 were 
about 3-fold lower than OspA28:mRFP1.  Metabolic labelling with tritiated palmitic 
acid (Fig. 8A) and size analysis of immunoprecipitated proteins (Fig. 8B) showed that 
both OspA17- and OspA28:mRFP1 were properly lipidated and processed.  
Incubation of intact cells with proteinase K did not affect motility, i.e. the integrity of 
the periplasmic flagellar proteins such as FlaB, nor OspA17:mRFP1 fluorescence, but 
OspA28:mRFP1-expressing cells lost their fluorescence.  OspA28:mRFP1 could be 
readily visualized under epifluorescence as a uniform red halo at the periphery of B. 
burgdorferi KU-1009 cells (Fig. 7B).  These results indicated surface exposure of 
OspA28-, but not OspAC17:mRFP1, which was confirmed by Western 
immunoblotting (Fig. 7A) and indirect fluorescent-antibody (IFA) microscopy (Fig. 
7C). 
 The above results suggested an OspA secretion signal between Cys17 and 
Asn28.  Therefore, we generated stepwise deletions of the OspA sequence in the 
OspA28:mRFP1 construct.  All deletion constructs were expressed at the same level 
as OspA28:mRFP1 (Fig. 7A), properly processed and lipidated (Fig. 8).  While 
deletion of 7 amino acids beyond Ser22 did not affect surface exposure, the additional 
deletion of Val21 led to subsurface localization of OspA20:mRFP1 (Fig. 7A).  This 
indicated that the minimal secretion signal for lipidated OspA consists of only five N-
terminal residues, including an apparently critical valine. 
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Figure 7.  Localization of OspA-mRFP1 fusions expressed by B. burgdorferi.  (A) 
Protease accessibility of N-terminal OspA-mRFP1 fusions expressed by recombinant 
B. burgdorferi B31-e2 cells (see Fig. 5 and text) was assessed by incubating intact 
cells with proteinase K (pK +) or control buffer (pK –), followed by epifluorescence 
microscopy and Western immunoblot analysis.  Cells were observed under phase 
contrast (Ph) or epifluorescence using a Texas Red (TR) filter block.  For Western 
immunoblotting, whole cell proteins fractionated by SDS-PAGE were probed with 
antibodies against mRFP1, OspA (w.t. surface control) and FlaB (periplasmic 
control).  Note the decrease in molecular mass of the OspA28- to OspA17:mRFP1 
fusion proteins.  (B) Peripheral localization of surface-exposed OspAN28-mRFP1 
visualized by epifluorescence microscopy of B. burgdorferi KU-1009 under 100 X 
magnification.  The bar is 2 µm in length.  (C) Indirect immunofluorescence 
micrographs confirming surface exposure of OspA28:mRFP1, but not OspA17: 
mRFP1.  Intact cells were incubated with polyclonal antisera against mRFP1 and a 
FITC-conjugated Goat anti-Rabbit antibody and observed under phase contrast (Ph) 
and epifluorescence using FITC and Texas Red (TR) filters.
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Figure 8.  Lipidation and processing of lipoprotein mutants expressed by B. 
burgdorferi.  (A) Lipidated OspA17- and OspA28:mRFP1 fusions were detected by 
radiography after metabolic labelling of B. burgdorferi B31-e2 and B313 harboring 
pRJS1008 and pRJS1009 (see Figs. 5  and 7) with tritiated palmitate.  Controls were 
cells carrying pBSV2 (neg.) or pBSV2 derivatives for expression of w.t. OspA, 
(OspAwt) or full-length non-lipidated mRFP1 (mRFP1).  Note that OspA28:mRFP1, 
marked with an open arrowhead, migrates between the 31 kDa OspA and 34 kDa 
OspB band present in B31-e2; OspA17:mRFP1 comigrates with OspA, but is readily 
visible when expressed in the OspAB-deficient B. burgdorferi B313 background.  (B) 
OspA17- to OspA28:mRFP1 fusions were immunoprecipitated with mRFP1 antisera 
from B. burgdorferi KU-1008 to KU-1009 and detected by Western immunoblotting.  
Note that lipoprotein sizes gradually increase from OspA17- to OspA28:mRFP1, 
indicating that the 1.7 kDa signal sequences of OspA17:mRFP1 as well as the other 
sub-surface fusions are cleaved by B. burgdorferi type II signal peptidase.
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To assess whether the subsurface lipoprotein mutants were retained in the 
cytoplasmic membrane or in the inner leaflet of the outer membrane, we analysed 
membrane-associated proteins in protoplasmic cylinder (PC) and outer membrane 
vesicle (OMV) preparations (Fig. 9).  B. burgdorferi OMVs were released by 
incubating cells in hypotonic citrate buffer, and PC and OMV fractions were 
separated on an isopycnic sucrose gradient.  OspA28:mRFP1, like w.t. OspA, was 
found predominantly in the OMV fraction.  W.t. OppAIV and subsurface OspA19– 
and OspA20:mRFP1 were detected predominantly in the PC fraction, demonstrating 
their retention within the IM (Fig. 9). 
 
Borrelia Lipoproteins Are Secreted by Default.  We next probed the sequence 
specificity of B. burgdorferi secretion signals by performing an extensive site-
directed mutagenesis of the OspA N-terminus (Figs 5, 6 and 10).  First, we tested 
whether Val21 was indeed critical for OspA surface localization.  Replacement of the 
hydrophobic Val21 in OspA28:mRFP1 with a polar serine (OspA28S21:mRFP1) or 
negatively charged glutamate (OspA28E21:mRFP1) did not alter lipoprotein 
localization, even though the same residues are present in identical positions in 
subsurface OspA19:mRFP1 and OppAIV, or OspA17:mRFP1, respectively (Fig. 7A).  
Val21 to Ser mutations in both w.t. OspA (OspAS21) and OspA(VNE)18 (OspA(VNES)18) 
confirmed this finding (Fig. 6A).  Furthermore, an Ala to Val mutation in subsurface 
OspA20:mRFP1 (OspA20:mRFP1V2) did not lead to surface localization.  These data  
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Figure 9.  Membrane localization of lipoprotein mutants expressed by B. 
burgdorferi.  (A) Coomassie-stained SDS-PAGE of B. burgdorferi B31-e2 cells 
expressing surface OspA28:mRFP1, subsurface OspA19- and OspA20:mRFP1 
fusions (see Figs. 5 and 7) or B313 cells expressing w.t. OspA or OspAΔL24 (see Figs. 
5 and 6).  PC, protoplasmic cylinder fraction; OM, outer membrane vesicle fraction 
enriched for OM proteins.  Note that the PC fraction also contains OM proteins due to 
the partial separation of OMVs from protoplasmic cylinders by treatment of Borrelia 
cells with hypotonic citrate buffer (Skare et al., 1995).  (B) Western immunoblots of 
PC and OMV fractions with antibodies against mRFP1 and controls OppAIV (PC) 
and OspA (OM). 
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indicated that Val21 by itself was neither sufficient nor essential for lipoprotein 
secretion. 
 Expanding our inquiry, we changed all residues from Lys18 to Asn28 in sets to 
alanines.  All alanine mutants, i.e. OspA28(3A)20: , OspA(5A)18:, OspA(6A)20:, and 
OspA(3A)20/26:mRFP1, were protease-sensitive, indicating that they were surface-
exposed (Fig. 10). OspA(5A)18:mRFP1 for unknown reasons produced protease-
resistant mRFP1 aggregates.  This suggested that, in the absence of a specific IM 
retention signal, borrelial lipoproteins are deployed to the surface by default.  To test 
for an N-terminal retention signal, we fused mRFP1 to the N-terminus of OppAIV, 
our model subsurface lipoprotein.  As Val32 is predicted by the PSIPRED algorithm 
(Jones, 1999) to be the first structurally confined OppAIV residue, we fused the first 
31 amino acids of OppAIV to mRFP1.  Surprisingly, the resulting OppAIV31:mRFP1 
fusion was surface exposed (Fig. 10C).  This further supported our hypothesis of a 
default lipoprotein secretion pathway, and suggested that IM retention signals for 
OppAIV are confined to the structural protein. 
 
Negatively Charged Residues Can Act as Specific N-terminal Retention Signals.  
The lack of an OppAIV N-terminal IM retention signal led us to ask why 
OspA20:mRFP1 was retained in the IM.  As described above, substitutions of OspA 
Val21 did not change the fusion proteins surface localization, and we speculated that 
residues in the immediate N-terminus of mRFP1 (Ala2-Ser3-Ser4-Glu5-Asp6), in 
particular the two negatively charged Glu and Asp residues, might inadvertently 
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provide a retention signal for OspA20:mRFP1 and the shorter OspA:mRFP1 fusions.  
We therefore substituted both serines and the following Glu and Asp residues of 
OspA20:mRFP1 in sets to alanines.  Substitutions of Ser3-Ser4 to Ala-Ala 
(OspA20:mRFP1(2A)3), Glu5 to Ala (OspA20:mRFP1A5) and Asp6 to Ala 
(OspA20:mRFP1A6) did not alter protein localization, while the substitution of Glu5-
Asp6 to Ala-Ala (OspA20:mRFP1(2A)5) led to the release of the fusion protein from 
the IM and its display on the bacterial surface (Fig. 10B).  This suggested that 
negatively charged residues within the first nine N-terminal amino acids of the mature 
lipoprotein can retain lipoproteins in the B. burgdorferi periplasm. 
 
N-terminal Amino Acid Sequence Determinants of OspA surface exposure.  
Asp25 and Glu26 of OspA are in positions +9 and +10, i.e. one residue removed from 
where they potentially could serve as a retention signal.  To test whether a positional 
effect of negative charges alone is sufficient to retain OspA in the IM, we mutated 
both w.t. OspA or OspA28:mRFP1 proteins by either deleting Leu24 or replacing it 
with Glu, or by replacing Ser22-Ser23 with Glu-Asp.  All three OspA-mRFP1 fusion 
mutants, OspA28ΔL24-, OspA28E24-, and OspA28(ED)22:mRFP1 were expressed by 
KU-1039, KU-1043 and KU-1044, respectively, and remained surface-exposed (Fig. 
10A).  No B. burgdorferi transformants expressing the OspA Leu24 to Glu (OspAE24) 
and Ser22-Ser23 to Glu-Asp (OspAED22) were recovered, indicating that the 
introduction of additional negative charges into the N-terminus of OspA may be 
detrimental to the B. burgdorferi cell.  The deletion of Leu24 in w.t. OspA (OspAΔL24),  
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Figure 10.  Localization of OspA and OppAIV lipopeptide-mRFP1 fusion 
mutants expressed by B. burgdorferi.  Protease accessibility was assessed by in situ 
surface proteolysis of intact B. burgdorferi B31-e2 cells expressing recombinant 
proteins (see Fig. 5 and text).  Cells were incubation with proteinase K (pK +) or 
control buffer (pK –), followed by epifluorescence microscopy and Western 
immunoblot analysis.  Cells were observed under phase contrast (Ph) or 
epifluorescence using a Texas Red (TR) filter block.  For Western immunoblotting, 
whole cell proteins fractionated by SDS-PAGE were probed with antibodies against 
mRFP1, OspA (w.t. surface control) and FlaB (periplasmic control). (A) Protease 
accessibility of OspA28-mRFP1 mutants.  Note that OspA28(5A)18:mRFP1 appears 
succeptible to protease, i.e. surface-exposed, along the borrelial cell, but forms polar 
protease-resistant aggregates.  (B) Localization of OspA20-mRFP1 mutants.  Note 
that only the OspA20:mRFP1(2A)5 mutant is released from the IM to the surface.  (C) 
Protease accessibility of OppAIV31: mRFP1.
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however, was tolerated.  Although OspAΔL24 was still detected on the cell surface by 
immunofluorescence microscopy (Fig. 6B), densitometry on Western immunoblots 
(Fig. 6A) and on Coomassie-stained SDS-PAGE gels (not shown) indicated that 
about two thirds of the mutant OspA was protease-resistant.  In contrast to the 
subsurface OspA:mRFP1 mutants, which associated predominantly with the IM, 
OspAΔL24 was found in the OM at w.t. OspA levels (Fig. 9).  W.t. lipidated OspA and 
OspAΔL24 extracted from B. burgdorferi membranes by Triton X-114 detergent were 
equally protease-sensitive (not shown), refuting the already remote possibility that 
deletion of Leu24 would render the numerous aliphatic and aromatic residues 
throughout the OspA molecule intrinsically resistant to cleavage by proteinase K 
(Keil, 1992).  This indicated that OspAΔL24 is released from the IM, but accumulates 
in the inner leaflet of the OM because of a defect in efficient translocation through the 
OM. 
 
Discussion 
In this study, we analyzed the peptide sequences targeting spirochaetal lipoproteins to 
different cellular compartments by using two model surface and subsurface Borrelia 
lipoproteins, B. burgdorferi OspA and OppAIV.  We demonstrated that the ‘+2 rule’ 
established for E. coli IM and OM lipoproteins does not apply to borrelial 
lipoproteins.  To the contrary, fusions of N-terminal tether lipopeptides of both OspA 
and OppAIV mediated the secretion and surface display of an inert fluorescent 
reporter protein, mRFP1, and an extensive mutagenesis of the OspA lipopeptide 
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tether showed that secretion is largely independent of peptide sequence. Supporting 
the latter, the N-termini of mature surface lipoproteins are not conserved beyond 
orthologous or paralogous lipoprotein protein families such as the OspC/Vsps  or 
OspEF/Erps (Zückert et al., 2001; Stevenson et al., 1996; Casjens et al., 2000; Fraser 
et al., 1997).  This indicates that in absence of protein-specific retention signals, the 
default pathway leads to the secretion of lipoproteins to the bacterial surface, and 
suggests that tether peptides of w.t. subsurface Borrelia lipoproteins do not per se 
contain signals that restrict the proteins to the IM. 
 Secretion also appears independent of overall lipoprotein secondary structure 
since both α-helical and β-sheet lipoproteins, e.g. OspC and OspA (Eicken et al., 
2001; Kumaran et al., 2001; Li et al., 1997), are found on the spirochaetal surface.  
Furthermore, the lipoproteins N-terminal tether peptides are neither structurally 
constrained in protein crystals nor are they predicted to form secondary structures, 
including transmembrane domains.  This is in contrast to surface lipoproteins of other 
diderm bacteria, which require structural information for their secretion.  A well-
studied example is PulA, a 116-kDa amylolytic enzyme secreted and anchored to the 
surface of the Gram-negative bacterium Klebsiella oxytoca (d'Enfert et al., 1987).  
PulA is exported by the main terminal branch of the general secretory pathway, i.e. a 
prototypical type II secretion system (Pugsley, 1993).  The PulA secretion signal 
resides within the tertiary structure of the protein in multiple, non-adjacent regions 
(Francetic and Pugsley, 2005; Sauvonnet and Pugsley, 1996).  In the absence of a 
type II secretion system, the penultimate Asp in PulA functions as IM retention/Lol 
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avoidance signal (Pugsley et al., 1990).  Other surface lipoproteins, such as the 
Bordetella pertussis SphB1 subtilisin (Coutte et al., 2003) or the Neisseria 
meningitidis NalP serine protease (van Ulsen et al., 2003), are autotransported via a 
C-terminal porin-like translocator domain (Oomen et al., 2004). 
 The mechanisms leading to the periplasmic retention of OppAIV and other 
subsurface Borrelia lipoproteins remain to be determined.  For E. coli lipoproteins, it 
has been suggested that IM retention/Lol avoidance involves the interaction of Asp+2 
and adjacent residues with the zwitterionic phosphatidylethanolamine in the IM 
bilayer (Hara et al., 2003).  In contrast to other bacteria, Borrelia lipid bilayers 
contain only phosphatidylglycerol and phosphatidylcholine (Belisle et al., 1994; 
Hossain et al., 2001), and it remains to be determined whether retention of IM 
Borrelia lipoproteins can be mediated by the interactions of N-terminal residues with 
the zwitterionic phosphatidylcholine.  Otherwise, lipoproteins might be retained in the 
IM by other lipid-protein or protein-protein interactions. 
 Negative charges within the lipoprotein tethers can disrupt lipoprotein 
secretion, but the underlying mechanisms may vary depending on peptide context.  
On one hand, the mRFP1 Glu+5Asp+6 IM retention signal of OspA19:mRFP1 bears 
similarity to the Asp+2 IM retention/Lol avoidance signal of E. coli lipoproteins, 
which can be further enhanced by additional negatively charged residues in the +3 
position (Robichon et al., 2003; Masuda et al., 2002; Terada et al., 2001).  Based on 
the determined structure of w.t. E. coli Lpp, the N-terminal tether of the three-
stranded coiled coil consists of only two residues, Cys+1 and Ser+2 (Shu et al., 2000).  
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Therefore, the +2 and +3 residues affecting the efficiency of sorting (Terada et al., 
2001) are proximal to the structurally confined Lpp N-terminus.  Likewise, Asp+6 is 
the predicted first structurally confined N-terminal residue of mRFP1 (Campbell et 
al., 2002), and the OspA19:mRFP1(2A)5 mutant may be released from the IM to the 
surface because of its altered tether-to-β-sheet transition.  On the other hand, 
OspAΔL24 is efficiently released from the IM, but is defective in translocation through 
the OM.  If the OspAΔL24 phenotype is solely due to the shifted position of negative 
charges within the OspA tether, identically positioned negatively charged dipeptides 
in the surface-localized OspA28E24– and OspA28ΔL24:mRFP1 fusions or the w.t. 
OspE/Erp proteins (Stevenson et al., 1996) would have to be somehow neutralized by 
other residues.  As precedent, the E. coli Asp+2 lipoprotein retention signal can be at 
least partially overcome by residues in the immediately adjacent +3 position (Gennity 
and Inouye, 1991; Terada et al., 2001).  Alternatively, a minimum tether length may 
be required for efficient secretion.  The mature N-termini of OspA and other Borrelia 
surface lipoproteins show no evidence of transmembrane domains, and lipidated 
recombinant proteins or fluorescent fatty acids insert spontaneously into the 
lipopolysaccharide-deficient apical leaflet of the Borrelia OM (Bunikis et al., 2001; 
Cox and Radolf, 2001).  Therefore, it can be all but ruled out that Borrelia surface 
lipoproteins are anchored via their triacyl moiety in the periplasmic leaflet and that N-
terminal mutations simply affect the spanning of the OM. 
 The borrelial lipoprotein secretion machinery likely contains components 
common to diderm bacteria as well as spirochaete-specific protein complexes.  
 60 
Orthologs of all essential components of the Sec translocase complex are present in 
Borrelia and all other spirochaetal genomes identified so far, and the same is true for 
the three enzymes required for lipoprotein modification, Lgt prolipoprotein 
diacylglyceryl transferase, Lsp signal II peptidase and Lnt apolipoprotein N-
acyltransferase.  Yet, with the exception of potential type II secretion and twin-
arginine translocation (Tat) orthologs in Leptospira, further Sec-dependent or -
independent bacterial protein secretion pathways appear to be absent in spirochaetes 
(Haake, 2000; Fraser et al., 1998; Seshadri et al., 2004; Nascimento et al., 2004).  
Together with the here described secretion-facilitating N-terminal peptide sequences, 
this virtually precludes the involvement of the two known lipoprotein secretion 
pathways.  Rather, the above-described potential analogies in OspA and Lpp sorting 
signal sequences may further argue for an involvement of a Lol-like pathway.  
Intriguingly, orthologs of the IM ABC transporter-like sortase complex LolCDE 
(Yakushi et al., 2000), the periplasmic lipoprotein-binding chaperone LolA (Yokota 
et al., 1999), but not the OM lipoprotein receptor LolB (Yokota et al., 1999), have 
been identified in the B. burgdorferi genome.  The lack of LolB in Borrelia might 
reflect the periplasmic or surface localization of Borrelia and E. coli major OM 
lipoproteins to different leaflets.  We therefore hypothesize that the lipoprotein 
transport pathway in Borrelia consists of LolCDE and LolA orthologs, but diverges 
from that of other diderm bacteria by utilizing a sofar unidentified module to facilitate 
translocation of surface lipoproteins through the OM. 
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 mRFP1 (Campbell et al., 2002) is currently the only fluorescent marker 
compatible with Sec-dependent export in diderm organisms, as the most commonly 
used fluorescent protein GFP is only periplasmically active when exported as already 
folded protein via the Tat pathway (Thomas et al., 2001; Feilmeier et al., 2000).  The 
results of this study expand the use of fluorescent proteins from the cyto- and 
periplasmic compartments to the bacterial surface of diderm bacteria.  mRFP1 and its 
recently described yellow-to-red fluorescent derivatives (Shaner et al., 2004) 
certainly have the potential to become valuable tools in further analyses of protein 
secretion in a variety of bacterial cells, including B. burgdorferi.  In particular, they 
will permit the use and recovery of viable cells in fluorescence-based screening 
approaches selecting for protein surface and subsurface localization. 
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Experimental procedures 
Bacterial strains and growth conditions.  B. burgdorferi B31-e2 (Babb et al., 2004) 
and B313 (Sadziene et al., 1993) are clones of type strain B31 (ATCC 35210).  B31-
e2 was generously provided by B. Stevenson (University of Kentucky, Lexington, 
KY) and contains plasmids cp26, cp32-1, cp32-3, cp32-4, lp17, lp38, and lp54 (Babb 
et al., 2004).  B313 carries cp26, cp32-1, cp32-2/7, cp32-3 and lp17 (Zückert et al., 
1999; Zückert et al., 2004).  B. burgdorferi were cultured in liquid or solid BSK-II 
medium at 34°C under 5% CO2 (Barbour, 1984).  E. coli strains TOP10 (Invitrogen, 
Carlsbad, CA) and XL10-Gold (Stratagene) were used for recombinant plasmid 
construction and propagation and grown in Luria Bertani Lennox broth (LB) or on 
LB agar (Difco). 
 
Lipoprotein Fusion and Point Mutants.  The recombinant plasmids generated and 
used in this study (see Fig. 5 and Table 1, which is published as supporting 
information) are derivatives of pBSV2 (Stewart et al., 2001), which replicates 
autonomously in both E. coli and B. burgdorferi and confers resistance to kanamycin.  
In all plasmid constructs, lipoprotein expression is driven by the constitutive B. 
burgdorferi flagellin flaB promoter (PflaB).  Transcriptional and translational fusions 
were generated by sequence overlap extension (SOE) PCR (Ho et al., 1989) using 
Platinum Pfx polymerase (Invitrogen, Carlsbad, CA) and the oligonucleotides listed 
in Table 2 (which is published as supporting information on the PNAS website).  
Fusion PCR amplicons were digested with BamHI/XbaI or BamHI/SphI for OspA or  
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Table 1. Strains and plasmids used in this study.
B. burgdorferi Strain Plasmid Description Comments !
KU-0998 pRJS0999 pBSV2.PflaBospA in B313 background 
KU-0999 pRJS1000 pBSV2.PflaBoppAIV in B31-82 background 
KU-1021 pRJS1004 pRJS0999 with (VNE)18 mutation in B313 background
KU-1022 pRJS1005 pRJS0999 with V18 mutation in B313 background
KU-1008 pRJS1008 pBSV2.PflaBospA17:mRFP1 fusion
KU-1009 pRJS1009 pBSV2.PflaBospA28:mRFP1 fusion
KU-1010 pRJS1010 pBSV2.PflaBoppAIV31:mRFP1 fusion
KU-1018 pRJS1012 pBSV2.PflaBospA25:mRFP1 fusion
KU-1019 pRJS1013 pBSV2.PflaBospA22:mRFP1 fusion
KU-1020 pRJS1014 pBSV2.PflaBospA19:mRFP1 fusion
KU-1024 pRJS1015 pBSV2.PflaBospA21:mRFP1 fusion
KU-1025 pRJS1016 pBSV2.PflaBospA20:mRFP1 fusion
KU-1027 pRJS1018 pRJS0999 with N20V21S22 to AAA mutation in B313 background
KU-1028 pRJS1019 pRJS1009 with N20V212S22 to AAA mutation  
KU-1029 pRJS1020 pRJS0999 with KQNV to VNES mutation in B313 background
KU-1030 pRJS1021 pRJS1009 with V21S point mutation
KU-1031 pRJS1022 pRJS0999 with V21S point mutation in B313 background
KU-1032 pRJS1023 pRJS1016 with RFP S3S4 to AA mutation  
KU-1033 pRJS1024 pRJS1016 with RFP E5D6 to AA mutation  
KU-1034 pRJS1025 pRJS1009 with V21E point mutation
KU-1035 pRJS1026 pRJS1019 with K18Q19 to AA mutation  
KU-1036 pRJS1027 pRJS1019 with S23L24D25 to AAA mutation  
KU-1037 pRJS1028 pRJS1019 with E26K27N28 to AAA mutation  
KU-1038 pRJS1029 pRJS0999 with L24 deletion in B313 background
KU-1039 pRJS1030 pRJS1009 with L24 deletion  
KU-1040 pRJS1031 pRJS1016 with RFP E5A mutation  
KU-1041 pRJS1032 pRJS1016 with RFP D6A mutation  
KU-1042 pRJS1033 pRJS0999 with L24E mutation in B313 background
KU-1043 pRJS1034 pRJS1009 with L24E mutation  
KU-1044 pRJS1035 pRJS1009 with S22S23 to ED mutation  
KU-1045 pRJS1036 pRJS0999 with S22S23 to ED mutation in B313 background
KU-1046 pRJS1037 pRJS1016 with A21V point mutation
KU-1047 pRJS1038 pRJS1030 with V21A point mutation
KU-1048 pRJS1039 pRJS1029 with V21A point mutation in B313 background
*Amino acids are indicated in single letter code with their position in the full-length preprotein (see also text).
! strains are in B. burgdorferi B31-e2 background unless noted otherwise.
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mRFP1 constructs, respectively, and ligated into pBSV2.  Point mutations were 
generated by either SOE PCR or using the QuikChange II XL site-directed 
mutagenesis kit (Stratagene).  All constructs were checked for mutations by 
sequencing (ABI BigDye Terminator cycle sequencing kit and ABI 3130xl Genetic 
Analyzer, Biotechnology Core Facility, KUMC).  B. burgdorferi cells were 
transformed by electroporation using 1-5 µg of plasmid DNA using established 
protocols (Stewart et al., 2001).  Transformants were selected in solid BSK-II 
containing 200 µg/ml kanamycin, and at least two independent clones were expanded 
in selective liquid BSK-II.  Plasmid profiles were determined by PCR using plasmid-
specific oligonucleotide primers (Purser and Norris, 2000; Labandeira-Rey and Skare, 
2001).  The resulting recombinant strains are listed in Table 1 (see supporting 
information). 
 
Protein Gel Electrophoresis and Immunoblot analysis.  Proteins were separated by 
sodium dodecyl sulfate-12% polyacrylamide electrophoresis (SDS-PAGE) and 
visualized by Coomassie blue staining.  For immunoblots, proteins were 
electrophoretically transferred to nitrocellulose membranes (Immobilon-NC, 
Millipore) using a Transblot-SD Semi-Dry Transfer Cell (Bio-Rad) as described 
(Zückert et al., 1999).  Membranes were blocked and incubated with antibodies in 5% 
dry milk, 20 mM Tris-500 mM NaCl, 0.05% Tween 20 as described (Zückert et al., 
2004).  Antibodies used were anti-mRFP1 rabbit polyclonal antiserum (1:1,000 
dilution, a gift from P. Viollier, Case Western Reserve University, Cleveland, OH),  
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anti-OppAIV rabbit polyclonal antiserum (1:100 dilution, a gift from P.A Rosa, 
NIH/NIAID Rocky Mountain Laboratories, Hamilton, MT) (Bono et al., 1998), or 
monoclonal antibodies against B. burgdorferi OspA (1:25 dilution, H5332) (Barbour 
et al., 1983) and FlaB (1:25 dilution, H9724) (Barbour et al., 1986).  Secondary 
antibodies were alkaline phosphatase-conjugated goat-anti-rabbit IgG (H+L) or goat-
anti-mouse IgG (H+L) (Bio-Rad).  Alkaline phosphatase substrates were 1-Step 
NBT/NCIB (Pierce) for colorimetric and CDP-Star (Amersham Biosciences) for 
chemiluminescent detection. 
 
Protease and Antibody Accessibility Assays.  Spirochaetes were harvested, washed 
and resuspended in phosphate-buffered saline containing 5mM MgCl2 (PBS+Mg) as 
described (Barbour, 1984).  To assess protein surface exposure by protease 
accessibility, intact B. burgdorferi cells were treated in situ with 200 µg/ml proteinase 
K (Invitrogen) as described (Bunikis and Barbour, 1999).  As a control, cells were 
sonicated using a Branson Sonifier cell disruptor prior to protease treatment. 
 Antibody accessibility was assessed by indirect immunofluorescence (IFA) as 
described (Zückert et al., 1999).  Spirochaetes were resuspended in PBS+Mg 
supplemented with 2% bovine serum albumin (BSA) and incubated with the primary 
antibodies detailed above.  The secondary antibodies were FITC-labeled goat-anti-
rabbit IgG (whole molecule) (Sigma-Aldrich) or goat-anti-mouse IgG (H+L) 
(Kierkegaard & Perry Laboratories).  Cells were analysed by epifluorescence 
microscopy using a Nikon Eclipse E600 microscope fitted with FITC-HYQ and 
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Texas Red HYQ filter blocks and a QImaging Micropublisher Digital CCD color 
camera.  Digital images were processed using Adobe Photoshop CS and ImageJ 
version 1.33u (NIH) for Macintosh on an Apple Powermac G5. 
 
Membrane and Protein Fractionations.  Outer membrane vesicles (OMVs) were 
isolated and purified by treatment of B. burgdorferi cells with low pH, hypotonic 
citrate buffer followed by isopycnic sucrose gradient centrifugation as described 
(Skare et al., 1995).  Briefly, early exponential phase B. burgdorferi cells were 
washed in 1x PBS containing 0.1% BSA, resuspended and incubated under vigorous 
shaking for 2 hrs in 25 mM citrate buffer, pH 3.2, containing 0.1% BSA.  OMVs and 
protoplasmic cylinders (PCs) were fractionated by ultracentrifugation in a 
discontinuous gradient of 56, 42, and 25 % (wt/wt) sucrose in citrate buffer using a 
Beckman L8-80M centrifuge, SW28 rotor and 25x89 mm Ultra-Clear ultracentrifuge 
tubes.  Fractions were washed and resuspended in 1x PBS containing 1mM PMSF. 
Membrane proteins were extracted by detergent solubilization using a 
protocol modified from Brandt et al. (Brandt et al., 1990) and Nally et al. (Nally et al., 
2001).  Briefly, harvested B. burgdorferi cells were solubilized overnight in ice-cold 
PBS-Mg containing 2% (v/v) Triton X-114 with rotation at 4°C.  Insoluble PC 
material was removed by centrifugation and the supernatant was phase-separated at 
37°C for 15 min and centrifuged to obtain the aqueous periplasmic and detergent-
soluble membrane fractions. Both the aqueous and detergent fractions were washed 
three times by addition of ice-cold Triton-X114 to the aqueous phase at 2% final 
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concentration, or ice-cold PBS+Mg to the detergent phase and phase-separated as 
above.  Proteins were concentrated by acetone precipitation. 
 
Radiolabeling of Borrelia Lipoproteins.  Lipidation of recombinant proteins was 
confirmed by metabolic labeling of B. burgdorferi with [9,10(n)-3H]palmitic acid 
(Amersham Biosciences) using a protocol modified from Brandt et al. (Brandt et al., 
1990).  Briefly, about 5x107 early log-phase spirochaetes were washed once with 
PBS+Mg and resuspended in 1.0 ml fresh BSK-II containing 150 µCi tritiated 
palmitate and appropriate antibiotics.  The cells were then incubated at 34˚C for 48 h, 
washed twice with PBS+Mg, and resuspended in SDS-PAGE sample buffer.  Next, 
whole cell proteins were fractionated by SDS-PAGE.  The gels were stained with 
Coomassie brilliant blue, destained and fixed with methanol and acetic acid, and 
immersed in Amplify fluorographic reagent (Amersham Biosciences) for 30 minutes.  
After drying under vacuum for 2h at 60°C, the gels were exposed overnight to x-ray 
film at -80°C. 
 
Immunoprecipitation.  Proteins were isolated from whole cell lysates by 
immunoprecipitation using protein-specific antibodies and Protein A Sepharose 4 
Fast Flow beads (Amersham Biosciences) following the manufacturers’ instructions.  
Briefly, 5x109 spirochaetes were harvested and washed twice in ice-cold PBS-Mg.  
Cells were resuspended in 1 ml of ice-cold NP40 lysis buffer (150 mM NaCl, 1% 
IGEPAL CA-630, 50 mM Tris, pH 8.0, 1 mM PMSF) and lysed on ice for 15 min 
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with occasional gentle mixing.  Cellular debris was pelleted by centrifugation for 10 
min at 15,000 x g and 4˚C.  500 µl of the supernatant was incubated with 5 µl of 
polyclonal anti-mRFP1 for 1 h at 4˚C with over-end mixing.  Next, 50 µl of washed 
protein A beads were added and the incubation continued for 1 h, after which the 
beads were washed 3 times with lysis buffer and once with 50 mM Tris, pH 8.0.  
Immunoprecipitated protein was released from the beads by boiling for 4 min in 50 µl 
of SDS-PAGE sample buffer, collected in 40 µl of supernatant and analysed by SDS-
PAGE. 
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Chapter III: Single deletions in the unstructured N-terminus of Borrelia 
burgdorferi lipoprotein OspA reveal a sequential order of translocation through 
the outer membrane 
 
Abstract 
Borrelia burgdorferi surface lipoproteins are essential to the pathogenesis of Lyme 
disease, but the mechanisms responsible for their localization are only beginning to 
emerge.  We have previously demonstrated the critical nature of the unstructured 
amino-terminal ‘tether’ domain of the mature lipoprotein for sorting a fluorescent 
reporter to the Borrelia cell surface.  Here, we provide additional insights into the role 
of the lipoprotein tether by showing that deletion of four key amino acid residues 
within this tether results in the inefficient translocation of the major surface 
lipoprotein OspA across the Borrelia outer membrane.  The carboxy-termini of these 
mutants are surface-exposed, but the proteins fail to be fully translocated. An 
expansive in silico analysis indicates that amino-terminal disorder is a feature 
common to lipoproteins of all bacterial phyla.  This suggests an important role for 
lipoprotein tethers in proper localization within the B. burgdorferi cell envelope as 
well as the membranes of other distantly related bacteria. 
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Introduction 
Bacterial lipoproteins are a ubiquitous subclass of membrane proteins characterized 
by a covalent N-terminal acyl modification (Hantke,1973).  The addition of a fatty 
acid group to the peptide allows for the sequestration of the protein to a membrane 
compartment, consequently permitting these proteins to perform functions specific to 
the membrane leaflet into which they are anchored.  These specialized proteins have 
well-documented roles in bacterial physiology and pathogenicity.  For example, 
lipoproteins present in the periplasmic leaflet of the Gram-negative outer membrane 
(OM) help anchor the rigid peptidoglycan-based cell wall to the fluid bacterial 
membrane (Cascales,2002), and surface-localized Bordetella pertussis SphB1 is 
required for the maturation of its major antigen, filamentous hemagglutinin 
(Coutte,2003)).  Borrelia burgdorferi, the bacterial agent of Lyme disease and the 
focus of this study, possesses numerous surface lipoproteins, many of which have 
been found to contribute to the pathogenesis of the organism 
(Fraser,1997;Haake,2000). 
 All lipoproteins are synthesized in the cytoplasm with a signal II peptide that 
contains a ‘lipobox’ lipidation motif ending in an absolutely conserved cysteine 
residue (von Heijne,1989).  This signal sequence is removed following transport 
across the cytoplasmic membrane and the N-terminal cysteine becomes acylated, 
resulting in a mature lipoprotein attached to the periplasmic face of the cytoplasmic 
membrane (Sankaran,1994).  
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 Among the various strategies employed by bacteria for transporting proteins 
between and across membranes (Economou,2006), lipoproteins appear to use a 
dedicated system for proper cellular localization.  In Escherichia coli, a five-
component lipoprotein transport machinery (termed the Lol system for Lipoprotein 
Outer Membrane Localization) has been analyzed in great detail (for reviews, see 
(Narita,2004) and (Tokuda,2004)).  The E. coli Lol system sorts lipoproteins on the 
basis of the identity of the amino acid immediately adjacent to the fatty-acylated 
cysteine residue.  An aspartic acid at this ‘+2’ position results in inner membrane 
retention; otherwise, the lipoprotein is transferred to the periplasmic face of the outer 
membrane via a periplasmic chaperone. We previously ruled out a ‘+2-rule’ for 
transport of Borrelia lipoproteins and suggested that B. burgdorferi employs a 
modified lipoprotein transport mechanism based on an incomplete set of Lol proteins 
(Schulze,2006). 
 We have already performed an initial characterization of the N-terminal tether 
for OspA, a major B. burgdorferi surface lipoprotein and target of a first-generation 
Lyme disease vaccine (Schaible,1990;Li,1997;Pal,2004).  A fusion of the first 28 
amino acids of OspA to a monomeric fluorescent protein (OspA28:mRFP1) resulted 
in the lipidation and successful transport of the reporter to the Borrelia cell surface 
(Schulze,2006).  Truncation mutations of the N-terminus revealed that sequence 
information sufficient for surface localization of the reporter was present within the 
first five residues (lipoCys-17 through Val-21) of the mature OspA.  Empirical 
mutagenesis of the entire lipoCys-17 through Asn28 tether failed to reveal a mutation 
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that hindered transport of the reporter to the surface.  Negatively-charged residues in 
proximity to the N-terminal Cys appeared to function as inner membrane retention 
signals, but only in a particular context.  This led to our initial conclusion that, in the 
absence of a retention signal, Borrelia lipoproteins are transported to the cell surface 
by a default mechanism. 
 In this study, we further examined the role of residues within the tether of the 
OspA lipoprotein from B. burgdorferi.  Site-directed mutagenesis identified a region 
crucial for the transport of OspA across the outer membrane, and epitope-tagging of 
mutants revealed a potential sequential mode of transport across the membrane.  
Based on an extensive in silico analysis, we hypothesize that the N-terminal 
lipoprotein tethers of Borrelia, as well as those of other bacterial phyla, have evolved 
to retain a disordered conformation essential for proper lipoprotein localization and 
full biological functionality. 
  
Results 
OspA tether length itself does not dictate OM translocation.  Our preliminary 
analysis of the OspA tether suggested a default export pathway of lipoproteins to the 
Borrelia cell surface (Schulze,2006).  In the course of that study, we identified a 
single-residue tether deletion mutant of OspA, OspAΔL24.  When expressed in B. 
burgdorferi strain KU-1038, this mutant was largely resistant to in situ proteolysis by 
proteinase K (Fig. 11; Fig. 12B, compare OspAwt to OspAΔL24) and localized to the 
inner leaflet of the outer membrane.  
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 We chose to further analyze the OspAΔL24 mutant to determine the root cause 
for its mislocalization within the cell.  Additional mutagenesis revealed protease 
sensitivity of OspAΔL24 could be completely restored by the insertion of an alanine 
residue at an alternative location within the tether (Fig. 11; Fig. 12B, lanes 5 and 6).  
This suggested that the identity of the missing leucine residue itself was not the 
critical determinant of surface localization.  Indeed, a previously described removal 
of Leu24 from a full-length OspA tether fusion to mRFP1 (Fig. 11; Fig 12A, lanes 5 
and 6) had no detrimental effect on secretion to the cell surface.  Because of different 
contexts of the Leu24 deletion in wild-type OspA and the OspA28:mRFP1 fusion, we 
surmised that other factors were contributing to the surface localization of 
OspA28:mRFP1. 
 mRFP1 is a monomeric derivative of dsRed (Campbell,2002). The first five 
amino-terminal residues of dsRed do not appear in its crystal structure (PDB: IG7K, 
(Yarbrough,2001)) due to the absence of electron density, indicative of potential 
flexibility within this region.  Our original OspA:mRFP1 omitted only the N-terminal 
fMet of mRFP1.  Based on the dsRed structure, we were therefore likely including an 
additional flexible linker between the OspA tether sequence and the structurally 
confined region of mRFP1.  To determine whether this four residue linker of mRFP1 
(Ala2-Ser3-Ser4-Glu5) contributed to the observed discrepancy between the 
localization of OspAΔL24 and OspA28ΔL24:mRFP1, we removed it to yield the 
truncated reporter protein mRFPΔ4.  A OspA28:mRFPΔ4 fusion was transported as 
effectively to the surface of Borrelia as OspA28:mRFP1, the original fusion to full- 
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Figure 11. Peptide sequences of OspA lipoprotein mutants.  Deletions (Δ) and  
insertions (Ω) mutations with respect to the sequence of wild type (wt) OspA.  Δ 
symbols within the sequence mark the deletion, and Δ symbols above the sequence 
indicate the deleted amino acid below.  Gray shading indicates the structurally 
confined portion of the protein.  Underlined sequence indicates the portion of the 
construct derived from wild type OspA.  Mutant protein phenotypes are summarized 
by membrane (inner membrane, IM; outer membrane, OM), surface (surf) or 
periplasmic (peri) localization. 
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length mRFP1 (Fig. 12A).  Removal of Leu24 from this new fusion resulted in a 
phenotype that behaved in all respects like the OspAΔL24 mutant: 
OspA28ΔL24:mRFPΔ4 was resistant to proteinase K digestion (compare lanes 7 and 8 
of Fig. 12A and lanes 3 and 4 of Fig. 12B) and also localized to the outer membrane 
with the same efficiency as surface-exposed OspA28:mRFP1.  The Leu24 deletion 
mutant thus represents a lipoprotein with a true defect in translocation across the 
outer membrane (Fig. 12C, compare lanes 5 and 6 to lanes 1 and 2).  
 To determine whether the deletion of any single residue within the tether of 
OspA resulted in a general defect in transport of lipoproteins across the outer 
membrane, we chose a second residue, Asn20, and removed it from the tether of both 
wild-type OspA and OspA28:mRFPΔ4, creating OspAΔN20 and 
OspA28ΔN20:mRFPΔ4, respectively.  In both instances, this mutation had no effect on 
the transport of the respective lipoproteins to the cell surface (see Fig. 13A, lanes 3 
and 4; Fig. 13B, lanes 3 and 4).  
 Broadening our search, we next individually removed each of the remaining 
residues from the OspA tether to search for a phenotype similar to the Leu24 defect.  
Indeed, removal of Val21 and Ser at positions 22 or 23 had a sorting defect.  As with 
Asn20, deletion of residues 18-19 and 25-28 had no impact on cell surface 
localization of OspA (Fig. 13A).  Like OspAΔL24, the OspAΔV21 and OspAΔS22/23 
mutants localized to the OM with OspAwt-like efficiency and were resistant to 
proteinase K treatment (Fig. 13D).  However, the resistance to protease was 
approximately two-fold higher for the Val21 and Ser22/23 deletion mutants versus  
 79 
 
 
 
 
 
Figure 12. Role for OspA Leu24 for OM translocation.  (A) Epifluorescence  
micrographs of B. burgdorferi expressing various red fluorescent protein fusions 
before and after treatment with proteinase K (pK). Ph, phase contrast; TR, Texas Red 
filter. Supporting Western immunoblots for mRFP1, using surface-exposed OspA and  
periplasmic FlaB as controls are shown below.  (B) Proteinase K accessibility of 
OspA tether mutants compared to OspAwt.  FlaB is used as a periplasmic, protease-
resistant control.  (C) Membrane fractionation immunoblots of OspAΔL24:mRFPΔ4 
compared to surface-localized OspA28:mRFP1 and IM-localized OspA19:mRFP1 
controls (Schulze,2006)  OM, outer membrane vesicle fraction; PC, protoplasmic 
cylinder fraction (also containing intact cells; ref. (Schulze,2006)).  
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the Leu24 mutant (Fig. 13B). This indicates a clear hierarchy of importance for 
residues within the OspA tether for OM translocation. 
 A previous alanine scanning mutagenesis of the OspA28:mRFP1 fusion tether 
found no effect on surface localization (Schulze,2006).  To extend these studies to 
full-length OspA, we changed the VSSL sequence examined above to AAAA.  The 
resulting OspAAla(4) mutant still successfully translocated to the cell exterior (Fig 14A, 
lanes 3 and 4).  Changing the sequence to GGGG, however, resulted in a significant 
sorting defect: the resulting OspAGly(4) mutant was as protease-resistant as OspAΔV21 
and OspAΔS22 (Fig 14A, lanes 1 and 2) and was also found to localize to the OM (Fig. 
14B, lanes 3 and 4). Changing both serine residues at positions 22 and 23 to Glu/Asp 
respectively (Fig. 14A, 14C), resulted in the same OM mislocalization phenotype.  
Since removal of only certain residues from within the tether resulted in a defect and 
both OspAGly(4) OspA22(ED) were also found to be mislocalized, we were able to 
rule out a singular role of tether length in the translocation process.  Having identified 
the residues critical to OM translocation of OspA, we next sought to clarify their 
specific contribution to this process. 
 
Epitope-tagging of mutants reveals a potential C-terminal-first mechanism for 
lipoprotein surface exposure.  We engineered a hexa-histidine epitope tag with a 
Pro-Gly-Gly-Ser-Gly-Ala linker onto the C-terminal ends of OspA, OspAΔS22, and 
OspAΔL24.  Western blotting using an antibody to OspA showed that addition of this 
C-terminal tag to wild-type OspA did not affect the surface-exposure of the protein 
 82 
(Fig 14C, lanes 1 and 2). OspAΔS22-His and OspAΔL24-His, like their untagged 
counterparts, were largely protected from proteinase K treatment (Fig. 14C). Western 
blots using a monoclonal antibody against the C-terminal 6xHis tag, however, 
showed that the His tag for all three proteins was accessible to the protease.  
Accordingly, the apparent molecular weight of the OspA protein band decreased 
slightly following proteolytic treatment of the His-tagged constructs (Fig. 14C, lanes 
3-6).  This mobility shift was not observed when non-His tagged subsurface mutants 
of OspA were treated with proteinase K (see Fig 14A, lanes 1 and 2).  The estimated 
1-2 kDa decrease is comparable to the size increase seen upon adding the 1.3 kDa 
linker-His-tag peptide and suggests that only the extreme C-terminus is 
proteolytically cleaved.  This could indicate that the C-terminal His tag is exposed on 
the surface of the cell while the remainder of the protein, i.e. the OspA portion, 
remains sequestered in the periplasm.  If true, this would indicate that the subsurface 
mutant proteins may be locked in a transition state in their movement across the 
membrane and that translocation across the membrane originates at the C-terminal 
end of the protein.  This leads to a model of lipoproteins threading C-terminus-first 
through a pore in the Borrelia OM (Fig. 15). 
 
N-terminal disorder is a conserved feature of other bacterial lipoproteins. As a 
result of the great diversity of functions for bacterial lipoproteins, it is not surprising 
that there is little overall primary sequence conservation within these proteins outside 
of their lipobox.  We performed a comparative analysis of the N-terminal sequence  
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Figure 13. Localization of single-residue deletion OspA tether mutants.  (A) 
Protease accessibility assays for individual residue deletions from the OspA tether. 
(B) % proteinase K resistance of OspA mutants was calculated from Coomassie-
stained gel densitometry of three independent in situ proteolysis assays.  (C) 
Epifluorescence micrographs of B. burgdorferi B313 expressing various OspA tether-
mRFPΔ4 fusions. (D) Membrane fractionation immunoblots of single-residue OspA 
deletions mutants compared to OspAwt.  OppAIV serves as IM control.  Other labels 
for all panels are as in Fig. 2.  
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Figure 14. Localization of substitution OspA tether mutants and a C-terminal 
epitope tag.  (A) Proteinase K accessibility assay immunoblots for Val-Ser-Ser-Leu 
OspA tetrapeptide substitution mutants. (B) Membrane fractionation of the VSSL 
mutants compared to wild-type OspA. (C) Epitope-tagging of subsurface mutants 
selective surface accessibility. Note the 1-2 kDa shift of OspAΔS22-His6 and 
OspAΔL24-His6 proteins upon in situ proteolytic treatment.  Other labels for all panels 
are as in Fig. 2.  
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Figure 15.  Model for Borrelia lipoprotein OM translocation. Current model for a 
‘tail-first’ translocation of OspA (black with C-terminal epitope tag extension) 
through a hypothetical OM translocation core in either a partially unfolded or folded 
conformation. Certain tether deletion (Δ) mutants lead to an abortive translocation 
event, potentially due to a lack of interaction with a chaperone, releasing lipoprotein 
back to the periplasmic space.  The N-terminal acyl group of wild type OspA 
ultimately flips to the external OM leaflet through a ‘card-reader’ mechanism.  This 
likely requires a lateral opening of the proposed translocation/flippase channel.  
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from 90 experimentally verified E. coli K12 lipoproteins (Tokuda,2007) and 127 
known or predicted B. burgdorferi B31 lipoproteins (Setubal,2006).  Examination of 
the first twenty residues of the mature lipoproteins for these two organisms revealed 
no readily identifiable sequence motifs from positions +2 to +20 (Tables 4-6;Fig. 
16A).  Aside from the universally-conserved N-terminal cysteine at position +1, most 
other positions had low levels of residue conservation. 
 We next examined representative lipoproteins from all bacterial phyla and 
found that nearly all lipoproteins whose structures have been determined by X-ray 
crystallography share the common feature of containing an N-terminal region devoid 
of electron density (Table 3). Since structures have been solved for only a small 
percentage of E. coli and B. burgdorferi lipoproteins, we used the VSL2B algorithm 
(Peng,2006) to predict the likelihood of N-terminal disorder for all known and 
predicted lipoproteins for these two organisms.  The calculated mean probability of 
disorder was plotted as a function of residue position from the N-terminal cysteine.  
This analysis revealed a remarkable gradient for both E. coli and B. burgdorferi 
lipoproteins, with the calculated probability higher for residues proximal to the amino 
terminal cysteine compared to those further along the polypeptide chain (Fig. 16B).  
A comparison of E. coli lipoproteins to non-lipidated cytoplasmic and periplasmic 
proteins showed some degree of predicted amino terminal disorder for all three 
classes.  However, the unstructured region of lipoproteins was predicted to be about 
four times as long (~23 vs. ~6 residues; data not shown). As the VSL2B algorithm 
uses a probability of 0.5 to differentiate a predicted “ordered” residue from 
 90 
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Table 6. Residue Frequency by Position and Range
Escherichia coli K12
Residue +1 +2 +3 +4 +5 +6 +7 +8 +9 +10 +11 +12 +13 +14 +15 +16 +17 +18 +19 +20 Frequency +20 +15 +10 +5
A 0 13 5 6 5 6 5 8 10 9 9 9 4 12 11 14 8 6 14 8 A 162 112 67 29
C 90 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 1 1 1 C 5 2 1 0
D 0 9 10 6 7 7 12 7 4 8 4 4 4 5 5 7 4 5 4 1 D 113 92 70 32
E 0 0 2 5 5 10 7 3 9 2 6 6 6 1 7 5 1 4 5 8 E 92 69 43 12
F 0 0 0 1 0 1 1 1 1 2 1 1 2 2 0 1 5 3 1 1 F 24 13 7 1
G 0 3 6 0 3 9 2 7 7 9 4 8 8 7 4 7 7 7 5 8 G 111 77 46 12
H 0 0 2 5 3 0 1 3 1 4 2 1 1 0 1 1 2 0 2 0 H 29 24 19 10
I 0 1 1 2 3 1 5 4 1 3 7 1 2 4 2 8 4 4 4 3 I 60 37 21 7
K 0 2 1 11 7 9 4 6 9 5 8 7 5 7 4 3 2 7 2 9 K 108 85 54 21
L 0 1 3 4 2 1 2 4 5 5 2 3 3 7 4 7 7 7 5 4 L 76 46 27 10
M 0 0 1 2 1 0 1 2 1 2 1 3 2 3 3 1 1 2 0 0 M 26 22 10 4
N 0 6 7 8 7 5 5 7 5 5 6 1 5 2 6 4 3 6 8 3 N 99 75 55 28
P 0 0 1 5 14 6 8 10 4 10 5 11 10 9 5 6 10 4 5 11 P 134 98 58 20
Q 0 6 10 5 5 7 5 7 9 4 5 6 6 4 7 4 10 4 10 6 Q 120 86 58 26
R 0 0 1 4 4 5 2 4 4 1 2 2 2 2 3 0 2 2 3 5 R 48 36 25 9
S 0 30 23 8 16 10 6 6 4 5 10 14 9 5 12 4 5 7 8 6 S 188 158 108 77
T 0 11 9 11 7 6 10 7 9 9 8 2 11 9 7 8 6 11 3 6 T 150 116 79 38
V 0 8 5 5 0 3 9 3 5 6 10 6 6 9 7 9 6 7 9 7 V 120 82 44 18
W 0 0 2 1 0 1 0 0 1 0 0 1 2 1 1 0 2 2 0 0 W 14 10 5 3
Y 0 0 1 1 1 3 5 1 0 1 0 3 2 1 1 1 5 1 1 3 Y 31 20 13 3
Borrelia burgdorferi B31
Residue +1 +2 +3 +4 +5 +6 +7 +8 +9 +10 +11 +12 +13 +14 +15 +16 +17 +18 +19 +20 Frequency +20 +15 +10 +5
A 0 12 6 0 11 2 4 3 3 6 6 3 13 5 4 5 0 2 5 9 A 99 78 47 29
C 127 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 C 2 2 0 0
D 0 7 0 16 19 6 15 13 15 7 4 8 6 8 5 8 9 7 6 5 D 164 129 98 42
E 0 3 3 5 3 6 11 19 10 11 13 13 5 10 12 11 9 13 14 8 E 179 124 71 14
F 0 3 5 16 6 1 1 1 2 1 3 5 3 5 6 4 3 4 2 3 F 74 58 36 30
G 0 2 2 1 13 1 10 2 4 2 3 3 7 2 7 7 6 5 6 12 G 95 59 37 18
H 0 0 2 4 1 0 1 0 0 0 1 2 1 3 0 1 1 2 0 0 H 19 15 8 7
I 0 1 9 9 3 12 10 8 8 7 7 8 7 5 9 14 8 7 6 13 I 151 103 67 22
K 0 33 5 11 6 21 12 20 14 24 24 17 23 17 15 21 28 17 27 19 K 354 242 146 55
L 0 2 22 2 1 8 9 6 15 12 6 7 9 10 6 9 12 8 16 5 L 165 115 77 27
M 0 1 0 1 1 1 1 0 3 2 0 1 0 4 3 0 1 1 0 1 M 21 18 10 3
N 0 33 17 23 14 26 10 16 9 23 10 25 11 9 14 16 12 9 8 10 N 295 240 171 87
P 0 0 11 4 6 4 2 6 7 2 5 3 1 3 7 3 4 1 3 6 P 78 61 42 21
Q 0 1 4 0 2 1 4 4 13 8 4 11 6 8 11 1 2 2 2 0 Q 84 77 37 7
R 0 3 0 1 2 5 1 2 3 3 7 2 3 4 0 1 3 2 9 4 R 55 36 20 6
S 0 14 22 12 20 19 15 12 14 6 15 12 14 13 11 3 6 24 11 15 S 258 199 134 68
T 0 3 12 5 7 10 9 10 2 4 10 3 10 5 5 14 10 6 2 6 T 133 95 62 27
V 0 4 4 2 11 1 8 1 2 6 7 2 4 10 6 5 6 12 5 3 V 99 68 39 21
W 0 0 3 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 W 7 6 6 4
Y 0 5 0 13 1 2 4 3 2 1 1 1 2 4 5 2 5 3 3 5 Y 62 44 31 19
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Figure 16. Sequence complexity and prediction of N-terminal disorder of E. coli 
and B. burgdorferi lipoprotein tethers.  (A) A LogoBar (Perez-Bercoff,2006) 
representation of the N-terminal sequence of known or predicted mature lipoproteins 
for E. coli and B. burgdorferi (Tokuda,2007,Setubal,2006) illustrates the complexity 
of the tether.  The height of each column is proportional to the lack of complexity at a 
given position. The columns are stacked from the bottom starting with the most 
frequently occurring residue at that position and continuing upward.  Below each 
column are the six most frequently occurring residues at each position, in order of 
frequency from top (bold) to bottom.  Colors represent residues with similar 
characteristics.  (B) The VSL2B algorithm (ref. (Peng,2006); 
http://www.ist.temple.edu/disprot/predictorVSL2.php) for disorder prediction was 
used to generate a probability of disorder for each residue in each of 90 E. coli K12 
lipoproteins (Tokuda,2007) and 127 known or predicted B. burgdorferi lipoproteins.  
The red line plots the average predicted disorder (left y-axis) as a function of position 
from the N-terminal lipidated cysteine (x-axis).  In addition to the mean disorder, the 
first and third quartiles are listed to illustrate the dispersion of the probability values.  
Columns in the background show the number of lipoproteins (right y-axis) predicted 
to contain a tether of a length within the range indicated on the x-axis (e.g. there are 
five E. coli lipoproteins predicted to have a tether of between 40 and 45 residues in 
length). 
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“disordered,” we used the same cutoff to estimate the tether lengths for lipoproteins 
of E. coli and B. burgdorferi. The average tether length for E. coli lipoproteins was 
found to be approximately 24 residues in length. The average tether length for B. 
burgdorferi lipoproteins was predicted to be much longer, at 53 residues, with 
numerous lipoproteins predicted to have tethers of 150 residues or greater. 
 
Discussion 
 In this study, we characterized and assigned a function to the OspA tether, the 
flexible unstructured region at the N-terminus of the OspA lipoprotein of Borrelia 
burgdorferi. We showed that a four-residue Val21-Ser22-Ser23-Leu24 sequence 
within the OspA tether contains information for optimal transport of the entire protein 
across the OM.  The individual removal of any of these four residues severely 
impacted OspA OM translocation.  Further analysis of C-terminally His-tagged 
mutants revealed a likely mechanism whereby OspA may cross the OM. We also 
presented preliminary evidence that tether domains may be a universal property of 
eubacterial lipoproteins.  
 There is little amino acid sequence similarity between mature lipoproteins, 
which likely reflects the enormous functional diversity of their globular moieties.  
Our work in this paper, together with structural determination and secondary 
structural predictions of numerous lipoproteins, suggests that the extreme amino-
terminus is often disordered (Table 3). Examination of lipoproteins from distantly-
related bacteria reveals that the N-terminal primary sequence of many mature 
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lipoproteins are well-populated by certain residues and sequences unlikely to be 
conducive to the formation of secondary structure, particularly Gly, Gln, Ser, Pro, 
Asp, Asn, Glu, and Lys (Romero,2001;Madan Babu,2002;Babu,2006;Peng,2006). 
Lys, Asn, Ser Asp and Glu, found to be especially common in regions of short 
disorder (Peng,2006), are the five most common residues within the first fifteen 
positions of the 127 known/predicted B. burgdorferi lipoproteins. 
The lipoprotein tether acts as a physical link between the lipidated, membrane-bound 
cysteine and the globular portion of the protein.  While the tethers themselves do not 
appear to be conserved at the level of their primary sequences, they do appear to be a 
common property of lipoproteins from all bacterial phyla.  Because lipoproteins have 
long been recognized as both virulence determinants and potent immunostimulatory 
molecules, much interest surrounds their accurate identification in the genomes of 
known and emerging pathogens 
(Aliprantis,1999;Brightbill,1999;Hirschfeld,1999;Haake,2000;Sutcliffe,2002;Juncker,
2003). Currently, prediction of peptide lipidation is dependent only on the presence of 
a calculated lipobox consensus sequence 
(Nakai,1999;Juncker,2003;Babu,2006;Setubal,2006).  The prediction of regions of 
disorder immediately adjacent to a signal-II peptidase recognition site may aid these 
lipoprotein prediction algorithms in the accurate identification of true lipoproteins. 
  The presence of N-terminal unstructured regions is not unique to those 
lipoproteins found in Borrelia.  Nearly all crystal structures of lipoproteins deposited 
in the Protein Data Bank are missing large segments of N-terminal sequence.  
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Lipoproteins that have not been crystallized show other indications of disorder: 
SphB1 of Bordetella pertussis is an autotransported surface-anchored lipoprotein that 
has an unusual N-terminal sequence containing a 14-glycine stretch followed by a 60-
residue proline-rich segment (Coutte,2003).  E. coli YilG, a predicted IM-localized 
lipoprotein of unknown function also has a proline-rich tether that may be as long as 
51 residues in length.  Other proteins have much shorter predicted tethers.  The Pal 
lipoprotein from E. coli, for instance, may have a tether of only two or three residues 
(PDB: 1EQ7, (Shu,2000)).  These residues are thought to form a cap-like structure 
that stabilizes an Lpp trimer (Shu,2000).  Together with the lipidated cysteine, this 
shortened tether may allow for Lpp to retain close proximity to the outer membrane 
while enhancing the stability of the membrane-peptidoglycan interaction that leads to 
the structural rigidity of the Gram-negative cell envelope.  Longer tethers may impart 
upon a lipoprotein a larger radius of gyration such that they can retain membrane 
localization without compromising their ability to bind to and interact with a partner.  
CspA/BbCRASP-1, a host complement factor H (FH)-binding lipoprotein of B. 
burgdorferi, may require its long amino-terminal extension of 46 residues in order to 
extend fully beyond the dense layer of highly-expressed OspA/OspC lipoproteins 
coating the borrelial cell surface (Cordes,2005;Bunikis,2001).  Truncation mutants of 
BbCRASP-1 indicate that the FH binding site is located at the extreme C-terminus, 
suggesting that this region of the protein could best be served projecting outward as 
far as practicable from the cell surface for optimal function 
(Kraiczy,2004;Cordes,2005).   
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 Another mechanistic possibility for tether function is as a means for protein 
turnover upon changing environmental conditions, akin to PEST sequences in 
eukaryotic proteins (Rogers,1986;Wright,1999;Fink,2005). The unstructured nature 
of the tether may prove to be the ideal substrate for proteolytic cleavage of a given 
lipoprotein.  Trypanosoma brucei, the African trypanosome, must rapidly exchange 
its GPI-anchored Variant Surface Glycoproteins (VSGs) with unrelated surface 
proteins as its life cycle transitions between its mammalian host and tsetse fly vector. 
These VSGs are proteolytically cleaved and released from the surface through the 
actions of a zinc metalloprotease and a phospholipase 
(Butikofer,2001;Gruszynski,2003;LaCount,2003;Grandgenett,2007). It would be easy 
to see how B. burgdorferi might likewise benefit from rapidly removing and 
exchanging immunodominant lipoproteins such as OspA and OspC from its surface 
during its tick-to-mammal transition. 
 The long unstructured tether domain may also be the location of a chaperone- 
or other partner-binding site.  We consider such a possibility in Fig 15. Binding of 
another protein to the tether may induce the formation of a secondary structural 
element that permits recognition by an OM translocation system.  This would be 
similar to the secretion mechanism of the Yersinia pseudotuberculosis effector YopE, 
where a disorder-to-order transition induced in its N-terminus by the Type III 
chaperone SycE permits its transport through the Type III needle apparatus 
(Rodgers,2008).  It seems unlikely that the VSSL sequence represents a specific 
sequence-dependent target for binding by a chaperone as it was not found in the N-
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terminus of any other B. burgdorferi lipoprotein. Unless OspA has a dedicated 
binding partner, the interaction of a chaperone with the tether may be governed by a 
sequence-independent interaction. 
 This study suggests that particular residues within the tether have important 
roles in surface localization, but the mechanism by which they promote OM 
translocation remains unclear. One possibility might involve their contribution to the 
overall flexibility of the N-terminus. Replacement of OspA residues 21-24 with 
alanines has no effect on OspA surface exposure, whereas substitution with glycines 
is detrimental.  As glycine residues are less likely to allow formation of secondary 
structural elements (Chakrabartty,1991), OM translocation may in part be dependent 
on the ability of the tether to undergo some degree of conformational organization 
resulting in the adoption of a translocation-competent state.  Transport of OMPs 
across the cytoplasmic membrane of bacteria has long been known to be dependent 
on the formation of secondary structure within the hydrophobic domain of the signal 
sequence (Emr,1983). The inability of the tether to be transported across the OM may 
therefore be due to an analogous problem arising from the presence of an overly 
flexible polyglycine tract. 
 Aside from structural functions, the tether of lipoproteins in Gram-negative 
bacteria contains information regarding membrane sorting.  For B. burgdorferi, an 
organism containing a diverse array of lipoproteins exposed on its cell surface, there 
is very little in the way of a defined ‘sorting signal’ that is based on peptide sequence 
and easily identifiable upon comparison of the N-termini of the known surface 
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lipoproteins.  It is for this reason that we previously hypothesized the existence of a 
default sorting pathway of lipoproteins in this bacterium (Schulze,2006).  In the 
absence of a straightforward sorting signal, the directed targeting of proteins within 
bacteria necessitates some pliability on the part of the targeting/secretion machinery.  
Often, the signals for peptide localization are degenerate in nature with numerous 
exceptions to an accepted ‘rule.’ The Lol system for lipoprotein localization 
represents a pertinent example of a ‘rule’ with many exceptions.  When it was first 
described two decades ago, an aspartic acid residue at position +2 of the mature 
lipoprotein was thought to be sufficient for retention of a lipoprotein in the inner 
membrane of Escherichia coli (Yamaguchi,1988).  Subsequent studies revealed that 
an aspartic acid at this position is indeed a very potent inhibitor of the interaction 
between a mature lipoprotein and the LolCDE complex resident in the inner 
membrane and that this inhibition may be dependent on the atomic distance between 
its Cα carbon and the negative charge of its side chain (Hara,2003).  Additionally, the 
presence of phosphatidylethanolamine in the E. coli membrane appears to contribute 
to the effectiveness of an Asp+2 avoidance signal.  It is now known, however, that 
Asp at this position can be replaced with Asn, provided that an Asp residue appears at 
the +3 position.  The E. coli lipoprotein AcrE (EnvC) contains such a signal and is 
thought to be localized to the cytoplasmic membrane (Seiffer,1993).  Though not 
found in the E. coli genome, lipoproteins containing Phe, Pro, Trp, and Tyr at the +2 
position and Asn at +3 will also be retained in the inner membrane 
(Seydel,1999;Terada,2001).  Glycine at +2 was shown to partially retain a lipidated 
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form of MalE in the E. coli inner membrane but results in the transport of RlpE, 
which also has Gly at +2, to the inner leaflet of the outer membrane 
(Seydel,1999;Wu, 2006). As suggested by Seydel et al., the E. coli Lol system may 
accommodate the existence of ambiguous sorting signals to permit localization of a 
lipoprotein in both membranes. 
 
More recent studies show that unlike the Enterobacteriaceae, Pseudomonas 
aeruginosa lipoproteins may depend on a ‘+3/+4-rule’ with Lys-Ser as the primary 
inner membrane retention signal (Narita,2007).  Our previous work excluded the 
possibility of either +2 or +3/+4 sorting rules for lipoproteins in Borrelia 
(Schulze,2006).  Further investigation of lipoprotein sorting signals from more 
diverse organisms may reveal that each species either has different mechanisms to 
cope with the transport of these unique proteins or that sorting uses sequence-
independent factors such as conformation to control localization, as has been 
suggested previously (Robichon,2003;Cullen,2004).  Because we observed the same 
phenotype for the single residue deletions of both wild-type OspA and the mRFPΔ4 
fusions, we can conclude that the information for membrane sorting is exclusive to 
the tether and not influenced in any way by the structural portion of the protein nor by 
the signal sequence, which remains unchanged for all constructs. 
 Though we show that tether length by itself is not the exclusive determinant of 
lipoprotein translocation across the outer membrane, it may play a role in 
combination with other signals.  We show in this paper that removal of Leu24 from 
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OspA results in an OM translocation defect but that the leucine at this position is not 
absolutely required for proper surface localization. The placement of an alanine 
elsewhere within the tether can overcome the transport defect.  Perhaps the critical 
VSSL region of OspA requires flanking regions of flexibility to function 
appropriately as a binding site.  The removal of Leu24 has less of a defect than 
removal of Ser22/23 or Val21 and its role in translocation may therefore not be as 
critical as the other three residues.  Addition of the alanine at position +10 may be 
sufficient to compensate for the function of the leucine at position +8.   
Addition of C-terminal His-tags to both surface and subsurface lipoproteins suggests 
that some lipoproteins may traverse the Borrelia OM via a C-terminal first 
mechanism (Fig. 3D). Treatment of cells expressing these constructs with proteinase 
K revealed that only the His-tag (and six-residue linker) but not the mature portion of 
OspA was protease-accessible (i.e. surface exposed). It is unknown whether the 
translocation-impaired constructs are locked in a bona fide intermediate state of OM 
transport or whether addition of the His-tag results in the non-specific sampling of C-
termini through OM channels. If the lipoproteins are indeed locked in an intermediate 
state of translocation, it may be possible to identify novel components of the OM 
transport machinery via crosslinking and coaffinity purification experiments.  
The experiments performed in this paper represent further steps toward the goal of 
identifying regions and signals within lipoproteins that contribute to their ultimate 
placement within the bacterial cell envelope.  We have identified one such region 
within the tether of a major virulence determinant of Borrelia burgdorferi that is 
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critical for transport of the lipoprotein to the cell surface. Though different 
mechanisms and signals may be used for lipoprotein transport by different species of 
bacteria, the common feature of a lengthy disordered N-terminus may reveal insights 
into a shared property for these specialized proteins.  
  
Experimental procedures 
Bacterial strains and growth conditions.  OspA- strain B. burgdorferi B313 was 
used for expression of all constructs(Sadziene,1993). B313 is a clone of type strain 
B31 (ATCC 35210) and contains circular plasmids cp26, cp32-1, cp32-2/7, cp32-3 
and the single linear plasmid lp17 (Zuckert,1999; Zuckert,2004).  B. burgdorferi were 
cultured in liquid or solid BSK-II medium at 34°C under 5% CO2 (Barbour,1984).  E. 
coli strains TOP10 (Invitrogen, Carlsbad, CA) and XL10-Gold (Stratagene) were 
used for recombinant plasmid construction and propagation and grown in Luria 
Bertani (LB) broth or on LB agar (Difco). 
 
Lipoprotein Fusion and Point Mutants.  All mutations made in this study were 
constructed in pBSV2(Stewart,2001), an E. coli-B. burgdorferi shuttle vector 
conferring kanamycin resistance.  Expression of all lipoprotein constructs is under the 
control of the constitutive B. burgdorferi flagellin flaB promoter (PflaB). Point 
mutations were generated by using the QuikChange-II XL site-directed mutagenesis 
kit (Stratagene). pCSY6a-linkerHis is a pBSV2-derived plasmid containing an 
epitope-tagged copy of wild-type OspA under the control of the flaB promoter. A C- 
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Table 7. Bacterial Strains and Plasmids Used in this Study 
Strain/Plasmid   Description    Source/Reference 
Strains 
 Borrelia burgdorferi 
 B313   Clone of B31 ATCC 35210 (cp26, cp32-1,          (Sadziene,1995) 
    cp32-2/7, cp32-3 and lp17). OspA-. 
  
 Escherichia coli 
 Top10   F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15     Invitrogen 
    ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU 
    galK rpsL (StrR) endA1 nupG 
 XL-10 Gold  Tetr D(mcrA)183 D(mcrCB-hsdSMR-mrr)173     Stratagene 
    endA1 supE44 thi-1 recA1 gyrA96 relA1 lac The 
    [F’ proAB lacIqZDM15 Tn10 (Tetr) Amy Camr 
 
Plasmids 
 pRJS0998  pBSV2:PflaBospA             (Schulze,2006) 
 pRJS1029  pBSV2:PflaBospAΔL24             (Schulze,2006) 
 pRJS1030  pBSV2:PflaBospA28ΔL24-mRFP1            (Schulze,2006) 
 pRJS1036  pBSV2:PflaBospA22(ED)             This study 
 pRJS1040  pBSV2:PflaBospAΔL24ΩA27       This study 
 pRJS1041  pBSV2:PflaBospA28ΔL24-mRFPΔ4                   This study 
 pRJS1077  pBSV2:PflaBospA28-mRFPΔ4                                  This study 
 pRJS1078  pBSV2:PflaBospAΔN20                     This study 
 pRJS1130   pBSV2:PflaBospA(Ala)4                      This study 
 pRJS1131  pBSV2:PflaBospA(Gly)4                                 This study 
 pRJS1140  pBSV2:PflaBospAΔS22/23-His                    This study 
 pRJS1141  pBSV2:PflaBospAΔL24-His                    This study 
 pRJS1200  pBSV2:PflaBospAΔK18                       This study 
 pRJS1201  pBSV2:PflaBospAΔQ19                        This study 
 pRJS1202  pBSV2:PflaBospAΔV21                        This study 
 pRJS1203  pBSV2:PflaBospAΔS22/23                     This study 
 pRJS1204  pBSV2:PflaBospAΔD25                       This study 
 pRJS1205  pBSV2:PflaBospAΔE26                        This study 
 pRJS1206  pBSV2:PflaBospAΔK27                       This study 
 pRJS1207  pBSV2:PflaBospAΔN28                       This study 
 pCSY6a-linkerHis pBSV2:PflaBospA-His                     This study 
 106 
 
 107 
 
terminal six residue linker (Pro-Gly-Gly-Ser-Gly-Ala) precedes a hexhistadine tag. 
The OspAΔS22 and OspAΔL24 mutations were introduced into this plasmid by site-
directed mutagenesis.  All mutations and constructs were verified by sequencing 
(Center for Genetic Medicine, Genomics Core Facility, Northwestern University 
Medical Center, Chicago, IL).  B. burgdorferi cells were transformed by 
electroporation using 1-5 µg of plasmid DNA using established protocols 
(Stewart,2001).  Transformants were selected in solid BSK-II containing 200 µg/ml 
kanamycin, with three independent clones expanded in selective liquid BSK-II.  
Plasmid profiles were determined by PCR using plasmid-specific oligonucleotide 
primers (Purser and Norris, 2000, Proc Natl Acad Sci U S A, 97, 13865-70; 
Labandeira-Rey,2001).  The resulting recombinant strains are listed in Table 7. 
 
Protein Gel Electrophoresis and Immunoblot analysis.  Proteins were separated by 
sodium dodecyl sulfate-12% polyacrylamide electrophoresis (SDS-PAGE) and 
visualized by Coomassie blue staining.  For immunoblots, proteins were 
electrophoretically transferred to nitrocellulose membranes (Immobilon-NC, 
Millipore) using a Transblot-SD Semi-Dry Transfer Cell (Bio-Rad) as described 
(Schulze, 2006).  Membranes were blocked and incubated with antibodies in 5% dry 
milk, 20 mM Tris-500 mM NaCl, 0.05% Tween 20.  Antibodies used were anti-
mRFP1 rabbit polyclonal antiserum (1:1,000 dilution),  anti-OppAIV rabbit 
polyclonal antiserum (1:100 dilution) (Bono et al., 1998, Microbiology, 144 , 1033-
44), or mouse monoclonal antibodies against B. burgdorferi OspA (1:25 dilution, 
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H5332) (Barbour,1983) and FlaB (1:25 dilution, H9724) (Barbour et al., 1986, Infect 
Immun, 52, 549-54).  Secondary antibodies were alkaline phosphatase-conjugated 
goat-anti-rabbit IgG (H+L) or goat-anti-mouse IgG (H+L) (Bio-Rad).  Alkaline 
phosphatase substrates were 1-Step NBT/NCIB (Pierce) for colorimetric and CDP-
Star (Amersham Biosciences) for chemiluminescent detection. 
 
Protease and Antibody Accessibility Assays.  Spirochetes were harvested, washed 
and resuspended in phosphate-buffered saline containing 5mM MgCl2 (PBS+Mg) as 
described (Barbour,1984).  To assess protein surface exposure by protease 
accessibility, intact B. burgdorferi cells were treated in situ with 200 µg/ml proteinase 
K (Invitrogen) as described (Bunikis and Barbour, 1999, Infect Immun, 67, 2874-83).   
Cells were analyzed by epifluorescence microscopy using a Nikon Eclipse E600 
microscope fitted with a Texas Red HYQ filter blocks and a QImaging 
Micropublisher Digital CCD color camera.  Digital images were processed using 
Adobe Photoshop CS and ImageJ version 1.33u (NIH) for Macintosh on an Apple 
Macbook. 
 
Membrane and Protein Fractionations.  Membrane fractionation of Borrelia was 
performed as described earlier(Skare et al., 1995, J Clin Invest, 96, 2380-92;Schulze, 
2006).  
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Lipoprotein Sequence Analysis and Protein Disorder Prediction. The 90 
experimentally-verified E. coli K12 lipoproteins from (Tokuda,2007) and the 127 B. 
burgdorferi B31 lipoproteins identified as being part of the ‘liposet’ identified in 
(Setubal,2006) were used for sequence comparisons. LogoBar (Perez-Bercoff,2006) 
was used for creation of Figure 4. Predictions for protein disorder were performed 
using the VSL2B algorithm on the web-based DisProt site 
(http://www.ist.temple.edu/disprot/predictorVSL2.php). Control cytoplasmic and 
periplasmic proteins from E. coli were selected from a pool identified as such by both 
Swiss-Prot and from proteomic analysis performed in (Lopez-Campistrous,2005). 
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Chapter IV. Localization of Lipoproteins lp6.6 and BB0323 to Subsurface 
Membrane Compartments  
 
Abstract 
Lipoproteins are known to play numerous important roles in the physiology and 
virulence of bacteria. Most diderm organisms (those with two membranes) sort 
lipoproteins within the boundaries of the periplasmic space. Borrelia burgdorferi, the 
etiologic agent of Lyme disease, is unique among diderms because it has a large 
number of lipoproteins that are additionally localized to its cell surface. The process 
of differential sorting of bacterial lipoproteins has been studied for thirty years in 
Escherichia coli, yet only recently have attempts been made at understanding the 
lipoprotein sorting process in Borrelia. We have previously characterized the 
determinants of the B. burgdorferi surface lipoprotein OspA. In an effort to better 
understand the characteristics of native lipoproteins that reside in all three membrane 
compartments, we chose to analyze two additional lipoproteins with putative 
periplasmic localization. Here, we characterize lp6.6 (BBA62) and BB0323 and show 
that fusions of each to a red fluorescent protein (mRFPΔ4) localize predominantly to 
the periplasmic faces of the outer and inner membranes, respectively. We introduce 
the technique of plasmolysis to Borrelia to show that it may be useful in determining 
membrane localization of fluorescent lipoproteins. These fluorescent fusions can 
serve as the basis for further studies for elucidating the mechanisms whereby B. 
burgdorferi selectively localizes lipoproteins within its cell envelope.  
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Introduction 
The sorting of lipoproteins in Escherichia coli has been thoroughly dissected using 
numerous representative lipoproteins to illustrate the importance of the residue at the 
+2 position (and to a lesser extent the +3 position) for inner membrane (IM) retention 
(Narita,2004;Tokuda,2007). Many of the original experiments used fusions of the β-
galactosidase reporter (β-gal) to the peptidoglycan-binding lipoprotein Lpp to 
determine the effect of N-terminal mutagenesis on lipoprotein sorting 
(Yamaguchi,1988). Additional experiments have used alternative reporters such as 
the maltose-binding protein (MalE), bacteriophage T5-encoded lipoprotein (Llp), and 
monomeric red fluorescent protein (mRFP1) 
(Seydel,1999;Robichon,2003;Lewenza,2006). Through detailed comparison of 
sequences and analysis of mutant phenotypes, it was determined that an aspartic acid 
at the +2 position behaves as a strong Lol-avoidance signal, possibly because of 
interactions between its negatively-charged side chain and phosphatidylethanolamine 
phospholipids in the inner membrane (IM) (Hara,2003). The strength of IM retention 
can be modified by the identity of the amino acid at the +3 position (Seydel,1999) 
 
Characterization of lipoprotein sorting rules in other bacteria has lagged far behind 
the studies done in E. coli and other members of the family Enterobacteriaceae. It is 
now becoming increasingly apparent that different organisms may use very different 
signals to govern localization of their constituent lipoproteins. Pseudomonas 
aeruginosa, for example may rely on the identity of residues at the +3/+4 positions 
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(Narita,2007;Tanaka,2007). The Yersinia pestis lipoprotein YscJ is anchored into the 
IM regardless of the identity of the residues in the +2/+3 positions, suggesting an 
alternative signal for lipoprotein retention in that organism (Silva-Herzog,2008).  
 
We have already performed preliminary analyses on the sorting of the major surface 
lipoprotein of Borrelia burgdorferi, OspA (Schulze,2006;Schulze,2009)). The use of 
fluorescent fusions to the OspA tether result in the trafficking of the reporter protein 
to the cell surface. We have demonstrated the ability to restrict localization of the 
reporter to all three compartments using site-directed mutagenesis. As OspA is only 
native to the cell surface, however, we wished to make similar reporter fusions to 
proteins known to be native to the other two membrane compartments (the 
periplasmic faces of the inner and outer membranes). Reports of proteins localizing to 
these compartments in B. burgdorferi are sparse and based only on predictions of 
protein function.  
 
OppAIV is one of five homologues of a periplasmic binding protein for an 
oligopeptide permease (Bono,1998). We conclusively showed that it localizes strictly 
to the Borrelia inner membrane. However, a fusion of the N-terminal 31 amino acids 
(the signal II peptide and predicted tether) to mRFP1 was sorted to the cell surface 
(Schulze,2006). To better understand the sorting rules of Borrelia burgdorferi, we 
sought to identify additional candidate IM and OMIL (outer membrane, inner-
leaflet)-resident lipoproteins with which we could generate reporter fusions.  
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Aside from OppAIV, only IpLA7 has been shown by our laboratory to be an IM-
specific lipoprotein (vonLackum,2007). Our attempts at creating an IpLA7-mRFP 
fusion have been hampered by cloning difficulties. A recent transposon mutagenesis 
screen of the B. burgdorferi B31 genome identified a gene, BB0323, that when 
disrupted by the transposon, resulted in severe membrane blebbing. A LysM domain 
was predicted to be located near the C-terminus of the protein encoded by BB0323. 
LysM domains are frequently associated with binding to peptidoglycan cell wall 
structures (Bateman,2000;Buist,2008). Because B. burgdorferi is thought to have a 
cell wall closely associated with the IM (rather than the OM, as is common for most 
Gram-negative organisms), we hypothesized that BB0323 may be an IM-localized 
lipoprotein with a function analogous to Lpp or Pal of E. coli. 
 
No lipoproteins have been definitively characterized as OMIL lipoproteins in 
Borrelia. A previous analysis and characterization of the BBA62 gene product 
provided conflicting localization data, with membrane fractionation showing that 
lp6.6 was predominantly localized to the protoplasmic cylinder but Triton X-114 
phase separation showing localization to the outer membrane (Lahdenne,1997). 
Protease accessibility suggested that the protein was subsurface; however, these 
studies were performed in the pathogenic B. burgdorferi strain B31, known to express 
numerous surface-localized Osp proteins. Previous experiments have shown that 
these Osps may hinder protease and antibody accessibility to underlying smaller, 
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surface-exposed proteins or protein loops such as those found on the OM porin p66 
(Bunikis,1999).  
 
In this study, we used an OspAB-deficient B. burgdorferi strain (B313) to verify 
protease inaccessibility of lp6.6. We show that lp6.6 is indeed a subsurface 
lipoprotein. Fusions of a red fluorescent reporter to both lp6.6 and BB0323 indicate a 
periplasmic location of each, with the former localizing to the OM and the latter to 
the IM. We also show a potential role for plasmolysis in the determination of 
subsurface membrane localization of fluorescently-labeled lipoproteins. 
 
Results 
lp6.6 (BBA62) localizes to the inner leaflet of the outer membrane 
To definitively determine the localization of lp6.6, we used a combination of 
proteinase K accessibility and isopycnic sucrose density gradient centrifugation to 
reveal the true membrane topology of this lipoprotein. We cloned the bba62 locus 
(including its native promoter) into pBSV2, an E. coli – B. burgdorferi shuttle vector 
(Stewart,2001) and expressed the protein in B. burgdorferi strain B313, which is 
missing the linear plasmid containing the bba62 gene (lp54) (Sadziene,1995). 
Treatment of cells expressing lp6.6 with 200µg/ml proteinase K revealed that p6.6, 
like the control periplasmic flagellar protein FlaB, is not sensitive to the protease 
(Fig. 17A). Because strain B313 is missing lp54, it is also missing the gene encoding 
OspA that is normally used as a surface-localized control protein. We therefore used  
 115 
 
 
 
 
 
 
Figure 17.  Localization of lp6.6 and BB0323P25:mRFPΔ4. (A) Coomassie-
stained gel shows whole cell lysates from two separate clones of  pK-treated and –
untreated B. burgdorferi strain B313 expressing lp6.6 from its native locus on a 
shuttle plasmid (pRJS1055). Note the variable expression of OspC between the two 
clones but consistent profiles of other proteins. OspC is degraded by proteinase K 
treatment but lp6.6 and FlaB are not. (B) Membrane fractionations from wild-type 
B31-e2 show that lp6.6 has a clear association with the OM, similar to OspA. 
OppAIV is included as a strict IM-control. (C) Coomassie-stained gel of membrane 
fractions from B31-e2 expression either BB0323P25:mRFPΔ4 (off of pRJS1063) or 
lp6.6:mRFPΔ4 (off of pRJS1065). The lp6.6 fusion is clearly visible in the OMV 
fraction. (D) Western blot analysis of above fractions show clear confirmation that 
the lp6.6 fusion fractionates with the OM and BB0323P25:mRFPΔ4 is found only in 
the IM (protoplasmic cylinder) fraction.
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OspC instead. As seen on the Coomassie-stained gel, OspC is almost entirely digested 
whereas p6.6 is not. Note that lp6.6 migrates with an apparent mass of 10kD on SDS-
PAGE gels (Lahdenne,1997;Katona,1992). This finding verifies previous reports that 
lp6.6 has a subsurface localization. 
 
To determine which membrane lp6.6 is anchored into, we treated B31-e2 cells in a 
hypotonic citrate buffer and performed sucrose density gradient ultracentrifugation to 
separate outer membrane vesicles from the protoplasmic cylinder. Fig. 17B shows 
that unlike OppAIV, lp6.6 maintains a significant association with the OMV fraction, 
similar to that of OspA, a known surface lipoprotein. Together with its resistance to 
proteinase K digestion, we conclude that lp6.6 is a bona fide OMIL lipoprotein. 
 
An in-frame fusion of mRFPΔ4 (Schulze,2009) to the C-terminus of lp6.6 was cloned 
into pBSV2, producing pRJS1065. This plasmid was used to transform B. burgdorferi 
strain B31-e2 and resulted in the production of a protein of approximately 34kDa in 
size (Fig. 17C). Membrane fractionation clearly shows an association of this fusion 
protein with the OMV fraction in both a Coomassie-stained gel of the fractions (Fig. 
17C) and in a Western blot using antibodies against mRFP1 (Fig. 17D, right). 
Additionally, the OMV fraction itself was noticeably pink in color (data not shown). 
Together, these results demonstrate an OMIL localization of lp6.6. 
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A BB0323-mRFPΔ4 fusion localizes to the inner membrane of B. burgdorferi 
 
As the predicted BB0323 gene product contains a C-terminal LysM domain 
hypothesized to play a critical role in peptidoglycan binding, we opted to not fuse 
mRFPΔ4 to the carboxy-terminus of the full-length protein. We instead fused the N-
terminal 25 residues (up to Pro25) to mRFPΔ4 to determine whether BB0323 would 
be likely retained in the IM or sorted to the OMIL. This fusion was cloned into 
pBSV2, producing pRJS1063. Strains of B31-e2 that had been electrotransformed 
with this plasmid did not produce this protein in large amounts as seen on a 
Coomassie-stained gel of membrane fractions (Fig. 17C). However, unlike the 
fractions of the lp6.6-mRFPΔ4 fusion, the protoplasmic cylinder fraction was bright 
pink in color whereas the OMV fraction was white (data not shown). A confirmatory 
Western blot (Fig. 17D, left) shows that the BB0323 fusion fractionates exclusively 
with the PC fraction. This is the first indication that BB0323 may, like OppAIV and 
IpLA7, be an IM-localized lipoprotein. 
 
Plasmolysis of B. burgdorferi  
Though reliable and consistent, the fractionation of B. burgdorferi membranes is a 
laborious and time-consuming process. The process is no easier in other diderm 
bacteria. A technique involving plasmolysis of the inner and outer membranes has 
recently been applied for the study of lipoprotein localization and used with success 
in various members of the Enterobacteriaceae as well as in Pseudomonas aeruginosa. 
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Treatment of E. coli with 15% sucrose causes a localized retraction of the inner 
membrane from the OM-associated peptidoglycan cell wall to form so-called 
“plasmolysis bays” (Cook,1987;Mulder,1993;Lewenza,2006). Red fluorescent 
proteins that have been retained in the inner membrane are therefore easily seen in 
such cells as they follow the contour of the retracted membrane when visualized 
under fluorescence microscopy. Recent work has shown that treatment of 
Pseudomonas aeruginosa with 0.5M NaCL results in the same phenomenon 
(Lewenza,2008). We sought to determine whether plasmolysis might be a useful tool 
in directly visualizing membrane localization of lipoproteins in Borrelia. 
 
We chose four previously localized lipoprotein-reporter fusions from a previous study 
(OspA28:mRFP1 [OM], OspA19:mRFP1 [IM], OspA20:mRFP1 [IM], and 
OspAΔL24:mRFPΔ4 [OM], (Schulze,2009)) and expressed these constructs in B. 
burgdorferi strain B31-e2. Treatment of cells with 0.5M NaCl showed little 
difference between the cells when viewed under fluorescence microscopy (data not 
shown). However, treatment with 15% sucrose showed a faint but reproducible 
punctate pattern along the length of the spirochete for those constructs known to be 
localized to the inner membrane (Fig. 18). No pattern was seen for cells treated with 
PBS-Mg. We conclude that plasmolysis of B. burgdorferi may be a suitable 
supplementary test for confirmation of lipoprotein membrane localization. 
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Figure 18.  Plasmolysis assay. B31-e2 cells expressing one of four constructs with 
known membrane localization were treated with either PBS or 15% sucrose. As can 
be seen in lanes 4 and 6, punctate staining of mRFP corresponds to the formation of 
plasmolytic bays for the two IM-localized reporter proteins. No such staining is seen 
for either OspA28:mRFP1 nor OspAΔL24:mRFPΔ4. Abbreviations: Ph (Phase 
contrast), TR (Texas Red epifluorescence filter).
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Discussion 
 
We show here evidence that lp6.6 and BB0323, two B. burgdorferi lipoproteins with 
previously unknown or unconfirmed localization, are sorted to the periplasmic faces 
of the outer and inner membranes, respectively. Fusions of the full-length lp6.6 or the 
N-terminus of BB0323 to mRFPΔ4 localize within the periplasmic space and can now 
be further investigated for the presence of possible sequence-dependent and –
independent sorting signals that B. burgdorferi uses as a basis for their localization. 
We also provide evidence that osmotic shock of Borrelia cells can induce the 
formation of plasmolytic bays that may aid in the expedient determination of 
membrane localization for fluorescently-tagged lipoproteins. 
 
BBA62 (lp6.6), like OspA, is a lipoprotein that has been shown in numerous studies 
to be significantly downregulated during the growth of B. burgdorferi in the 
mammalian host (Lahdenne,1997;Yang,2000;Liang,2002;Brooks,2003). This 
downregulation appears to be RpoS-dependent in nature 
(Caimano,2005;Caimano,2007). A potential role for this protein has not been 
elucidated. However, the presence of BBA62 on the same linear plasmid (lp54) as 
ospA and similar patterns of regulation for lp6.6 and OspA may be indicative of a 
potential role in the midgut colonization of the B. burgdorferi arthropod vector, 
Ixodes scapularis. We show that this protein localizes preferentially to the OMIL. It 
is tempting to speculate that lp6.6 might be somehow connected to OM translocation 
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of OspA, considering the genes encoding each are located on the same plasmid and 
are up- and downregulated by similar environmental cues. Additional studies are 
required to determine whether such an association of two proteins on opposite leaflets 
of the OM might exist. 
 
Very little is known about the function of the BB0323 protein. Recent studies show 
that it is a highly immunogenic lipoprotein and that IgG antibodies to BB0323 are 
developed at both early and late stages of human infection with B. burgdorferi 
(Nowalk,2006; Tokarska-Rodak,2008). Insertion of the Himar1 mariner transposon 
into the BB0323 open reading frame results in serious membrane stability problems 
for the cell (Stewart,2004). This would seem to indicate a role for BB0323 in the 
maintenance of membrane integrity. The discovery of a LysM domain near the C-
terminus may provide a hint for this protein’s function. If indeed BB0323 has a 
purely structural function similar to that of Braun’s lipoprotein (Lpp), this may 
account for the finding that it is not reciprocally regulated like other immunogenic 
lipoproteins and explain why it is found at both early and late stages of B. burgdorferi 
infection in humans. To avoid disrupting a potential peptidoglycan-binding role for 
BB0323, we chose not to fuse mRFPΔ4 to the full-length protein. A further reason for 
avoiding a full-length fusion is that BB0323 has been suggested to be a substrate of a 
B. burgdorferi C-terminal protease, CtpA (Ostberg,2004). We therefore opted to 
make a short fusion of the signal peptide and portion of the predicted tether to 
mRFPΔ4 and found that this fusion (BB0323P25:mRFPΔ4) is retained exclusively in 
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the borrelial IM. Longer fusions of the BB0323 N-terminus to mRFPΔ4 may be 
warranted to conclusively determine the localization of the full-length protein. 
 
Regardless of the functions for lp6.6 or BB0323, the finding that these lipoproteins 
may preferentially be targeted to the IM or OMIL suggests that the transport of 
lipoproteins to the spirochetal cell surface may involve retention “checkpoints” in 
both membranes. After transport through the Sec apparatus, a strict decision appears 
to be made as to whether a lipoprotein is retained in the IM or shuttled across the 
periplasm to the OM. At the OMIL, a second recognition step occurs, determining 
whether the protein is further transported across the OM or is retained on the 
periplasmic face of the OM. The existence of such a system may, in part, explain our 
previous finding that single-residue deletions within the OspA tether are transported 
to the OM as efficiently as wild-type, but are unable to be secreted across the 
membrane (Schulze,2006;Schulze,2009). A failed recognition step at the OMIL may 
prevent transport from occurring and further investigation is needed such that a 
putative OM translocation complex might be identified.  
 
Together with our previous localization of OspA28:mRFPΔ4 and fusions created in 
this study, we have now isolated fluorescent lipoprotein fusions to the three possible 
membrane compartments of B. burgdorferi: BB0323 to the IM, lp6.6 to the OMIL, 
and OspA to the surface. This is important, because knowledge of lipoproteins that 
are naturally found in each of these three locations will help identify other 
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lipoproteins that may be targeted to the same position within the cell. This 
information will aid in the understanding of B. burgdorferi membrane architecture 
and may provide hints regarding the pathogenicity of this bacterium. 
 
The fluorescent reporters will enable us to further study the primary sequence 
requirements for lipoprotein localization in this organism. One approach might 
involve the use of a random mutagenesis / fluorescence-activated cell sorting (FACS) 
screen (as diagrammed in Fig 19). In such a screen, random mutagenesis would be 
performed on the N-terminal tether of a known surface-localized protein (i.e. 
Osp28:mRFP1). A library of mutants would be used to transform B. burgdorferi, and 
cells grown in batch would be subjected to multiple rounds of FACS. The initial 
rounds would remove those cells not expressing a red-fluorescent protein. Subsequent 
rounds would be preceded by in situ proteolysis with proteinase K, to cleave all 
surface proteins from the bacterium. Cells remaining red fluorescent would 
theoretically contain a mutation resulting in a subsurface localization of the reporter 
and could be collected by FACS. These cells could then be further examined by 
isolation of single colonies and examination of periplasmic localization via a 
combination of membrane fractionation and the plasmolysis assay described above. 
DNA sequence analysis would allow for the identification of the mutation. In theory, 
such a screen would allow for a rapid and exhaustive search of sequences which 
permit retention at the periplasmic faces of the inner and outer membranes. A similar 
screen that starts with IM and OMIL-retained lipoproteins (i.e. the BB0323 and p6.6  
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Figure 19.  FACS screen for lipoprotein localization. This diagram describes the 
fluorescence-based cell sorting assay proposed in the text. The randomly-
mutagenized plasmid library is generated in E. coli and used to transform B. 
burgdorferi. FACS discards cells not expressing red fluorescent protein. The cells are 
then treated with proteinase K to cleave known surface proteins (including surface-
localized mRFP1). If the cells remain fluorescent, it is likely that the mutations 
introduced a subsurface retention signal and these cells can be further examined by 
traditional methods. 
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fusions identified in this study) could assay for mutations permitting surface exposure 
of the reporter. Results from such experiments would provide valuable data on the 
sequence-dependent requirements of lipoprotein sorting for B. burgdorferi. 
 
Materials and Methods 
 
Plasmids and Strains 
B. burgdorferi strains B31-e2 and B313 have been described previously 
(Schulze,2006). See Table 9 for a list of strains and plasmids used in this study. 
Expression of BBA62 in B313 was achieved by amplifying the BBA62 gene and 1kb 
of flanking sequence with primers 1055-fwd/rev and cloning into the B. burgdorferi – 
E. coli shuttle vector pBSV2 to create pRJS1055. The BB0323 locus was amplified in 
the same fashion using primers 1057-fwd/rev to create pRJS1057. Fusion of full 
length-lp6.6 or BB0323P25 to mRFPΔ4 was performed using sequence-overlap 
extension (SOE, (Horton,1990) and pRJS1041 as the starting plasmid template. 
pRJS1041 contains the gene encoding the OspA28:mRFPΔ4 fusion under the control 
of the flaB promoter. The OspA28 portion of the gene was replaced by SOE with 
either full-length lp6.6 or BB0323P25  using flanking primers BamPflaB-fwd (5’) and 
1055-rev (3’) as above. Internal primer pairs used were 1063-fwd/rev for BB0323 or 
1065-fwd/rev for lp6.6 to generate plasmids pRJS1063 or pRJS1065, respectively. 
Electrotransformation and growth of B. burgdorferi was done as previously described 
(Schulze,2006). 
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Table 9. Bacterial Strains and Plasmids Used in this Study 
Strain/Plasmid   Description    Source/Reference 
Strains 
 Borrelia burgdorferi 
 B31-e2   Clone of B31 ATCC 35210 (cp26, cp32-1,  (Babb,2004) 
    cp32-3, cp32-4, lp17, lp38, lp54) 
 B313   Clone of B31 ATCC 35210 (cp26, cp32-1,          (Sadziene,1995) 
    cp32-2/7, cp32-3 and lp17). OspA-. 
  
 Escherichia coli 
 Top10   F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15     Invitrogen 
    ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU 
    galK rpsL (StrR) endA1 nupG 
  
Plasmids 
 pRJS1009  pBSV2:PflaBospA28:mRFP1           (Schulze,2006) 
 pRJS1014  pBSV2:PflaBospA19:mRFP1           (Schulze,2006) 
 pRJS1016  pBSV2:PflaBospA20:mRFP1           (Schulze,2006) 
 pRJS1041  pBSV2:PflaBospA28ΔL24-mRFPΔ4          (Schulze,2009) 
 pRJS1055  pBSV2: lp6.6locus                     This study 
 pRJS1057  pBSV2:BB0323locus                     This study 
 pRJS1063  pBSV2:PflaBBB0323P25:mRFPΔ4        This study 
 pRJS1065  pBSV2:PflaBlp6.6: mRFPΔ4                    This study 
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Protease Accessibility and Membrane Localization 
Proteinase K accessibility and sucrose density gradient ultracentrifugation for 
membrane fractionation were performed as described previously (Schulze,2006). 
 
Plasmolysis of B. burgdorferi cells 
Two 1.0ml tubes of actively-growing cultures of B. burgdorferi strain B31-e2 that 
had been electrotransformed with one of four plasmids (pRJS1009, pRJS1014, 
pRJS1016, or pRJS1041) were spun down for 5 minutes and washed once with 1.0ml 
ice-cold PBS + 5mM MgCl2. To one tube, the pellet was resuspended in 50.0µl of 
PBS-Mg. To the other, 50.0µl of plasmolysis buffer (15% sucrose, 25mM HEPES, 
pH 7.4, 20mM NaN3) was added. Tubes were kept on ice for 10min and cells were 
visualized under epifluorescence microscopy using a Texas Red filter. 
 132 
Chapter V: Use of Mislocalized Epitope-Tagged Mutants of Borrelia burgdorferi  
 
OspA to Search for an Outer Membrane Lipoprotein Transporter 
 
 
Abstract 
In Borrelia burgdorferi, the final step in surface exposure of a lipoprotein involves 
translocation across the outer membrane. Our understanding of this mechanism is 
incomplete as no putative transporters have been identified to date. Here, we take the 
first steps toward identifying candidate components that may be involved in this 
process. Deletion of residue Ser22 from the major B. burgdorferi surface lipoprotein 
OspA results in mislocalization of the protein to the inner leaflet of the outer 
membrane. Epitope-tagging of both this mutant and the wild-type protein allow 
comparisons to be made of protein-protein interactions involving OspA when it is 
present on opposing leaflets of the same membrane. We use coaffinity purification 
and introduce an application of Multi-dimensional Protein Interaction Technology 
(MudPIT) analysis to survey the Borrelia outer membrane for components of a 
translocation complex. 
 
Introduction 
The presence of proteins on both sides of a bacterial membrane implies a mechanism 
for transport across that membrane. Many systems exist for the purposes of protein 
secretion across bacterial membranes. Outside of Borrelia burgdorferi, the presence 
of lipoproteins on the surface of Gram-negative cells is unusual, with only a handful 
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of examples known. These proteins are localized to the surface using established 
mechanisms, sometimes dedicated to the transport of a single known substrate. PulA 
uses a Type-II secretion apparatus for its secretion(Sandkvist,2001). SphB1 and NalP 
are lipoproteins from Bordetella pertussis and Neisseria meningitidis that use an 
autotransporter (Type-V) pathway for their placement on the cell surface 
(Coutte,2001;van Ulsen,2003). Borrelia burgdorferi has numerous lipoproteins on its 
surface, many of which are secreted to the surface by a default pathway using an as-
of-yet-identified mechanism (Schulze,2006).  
 
Searches of the B. burgdorferi genome for homologues of Type II secretion system 
components have failed to yield anything that might function analogously to the Pul 
secreton or other similar secretion machineries. Additionally, analyses of the primary 
sequences and crystal structures of these surface lipoproteins have not revealed the 
presence of autotransporter domains. We hypothesize that a novel mechanism 
dedicated to lipoprotein secretion exists in the B. burgdorferi OM.  
 
A previous study from our laboratory showed that removal of single amino acid 
residues from the unstructured N-terminal tether of OspA was sufficient to prevent 
that lipoprotein from being transported to the cell surface (Schulze,2009). The 
addition of a C-terminal histidine-tag to OspA revealed that the entire protein is still 
transported to the cell surface whereas removal of Val21, Ser22/23, or Leu24 from 
the same OspA-His fusion inhibited OM translocation of the protein. Interestingly, 
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the epitope tag could be removed from OspA by in situ treatment of cells with 
proteinase K, whereas the remainder of the protein could not. This indicated the 
possibility that these individual residue deletions may result in the formation of a 
‘trapped’ translocation state of the peptide.  
 
As the mutation results in a phenotype that obviously impedes OM translocation, we 
took advantage of the C-terminal epitope tag to determine whether we could identify 
potential OspA binding partners by co-affinity immunoprecipitaion or Multi-
dimensional Protein Identification Technology (MudPIT). MudPIT allows for the 
rapid examination of complex protein mixtures (i.e. OM preparations) through the use 
of a coupled high-efficiency liquid chromatography / tandem mass spectrometry 
process (Washburn,2001;Washburn,2004). Importantly, if the subsurface OspA 
constructs were truly trapped in an intermediate state of OM translocation, we might 
be able to identify components of a putative OM translocon through a side-by-side 
comparison of OspA-His and OspAΔS22-His pull-downs. 
 
Results 
Co-affinity immunoprecipitation with epitope-tagged OspA 
His-tagged OspA and OspAΔS22 were previously demonstrated to be sorted to the B. 
burgdorferi cell surface and inner leaflet of the OM (OMIL), respectively. We 
expressed these proteins in the OspA- strain (B313) and then lysed the cells in the 
presence of 1% n-dodecyl-β-D-maltoside (DDM). We ran the contents of the cell 
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lysates over a cobalt affinity column to determine whether there were any stable 
interactions with periplasmic proteins resulting from the mislocalization of a surface 
lipoprotein in the OMIL. 
 
As can be seen in the silver-stained gel of the various fractions (Fig. 20), the 100mM 
imidazole elution fractions appear relatively clean and contain only a few major 
visible bands. A ~25kD protein appears to be present in the 100mM elution for all 
four samples, suggestive of a contaminant. Outside of this band, however, very little 
protein is seen for the untagged OspA constructs. OspC, a surface lipoprotein whose 
expression is often variable and inconsistent during in vitro growth 
(Ramamoorthy,1998) is expressed in the strain containing OspA-His but not that of 
OspAΔS22-His. Other minor bands of unknown nature appear in the elution fractions.  
 
Identification of bound proteins 
To verify the presence of OspC in the 100mM elution fraction of OspA-His, we 
performed Western blot analysis using a monoclonal antibody against OspC. As is 
evident from Fig. 21, OspC was confirmed to copurify to some degree with OspA-
His. An antibody against OspA verified that the pull-downs were relatively specific 
for the epitope-tagged versions of the proteins. We also probed the elutions for the 
presence of p13, a Borrelia OM porin protein and IpLA7, a known IM-specific 
lipoprotein. As expected, a Western against IpLA7 showed that it was present only in  
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Figure 20.  Co-affinity purification. This figure depicts a silver-stained gel loaded 
with samples from different washes and elutions for OspA, OspA-His, OspAΔS22, 
and OspAΔS22-His affinity purification on a cobalt resin column. A ~25kD band 
appears in the 100mM imidazole elution fractions for all five samples, indicative of a 
nonspecific (labeled N/S) contaminant. The variably expressed OspC is also evident 
in the strain expressing OspA-His but not OspAΔS22-His. 
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Figure 21.  Western analysis of co-affinity purified fractions. We used antibodies 
against OspC, OspA, p13, and IpLA7 to preliminarily determine whether any of these 
were found in the 100mM elution fractions. This figure shows a comparison between 
the cell lysate (L) fraction and the 100mM elution (E) fraction. OspC is identified as 
the band seen in Figure 20 for the strain expressing OspA-His. OspA is enriched in 
the elution fraction, indicating that the His-tag pull-down was effective. Use of 
polyclonal p13 antisera showed cross-reactivity with both OspA and OspC. The 
prominent band indicates that the p13 porin is not found in the elution fraction. The 
same is true for the IM lipoprotein IpLA7, used here as a negative control.
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the flowthrough and likely played no part in interactions at the OM. The p13 protein 
used for antibody production was purified from an outer membrane protein 
preparation and may explain why the antibody shows reactivity to both OspA and 
OspC (Noppa,2001). The Western analysis reveals that p13 (the lower band) is not 
specifically pulled down by the epitope-tagged OspA. 
 
We next used MudPIT analysis to determine the identity of the minor bands present 
in the sample. We show the thirty most abundant proteins from the samples in Tables 
11 and  12. Table 11 indicates which peptides were identified by the analysis as well 
as the percentage of the total sample corresponded to that peptide. NSAF ratios are 
shown to indicate whether there was a noticeable increase or decrease in the presence 
of a given protein between surface exposed OspA-His and subsurface OspAΔS22-His. 
As can be seen, many of these appear to be unlikely candidates for components of a 
putative OM translocon. Three proteins, CtpA, p66, and BB0028 are of special 
interest. The thirty peptides displayed in Tables 1 and 2 account for 96.98% and 
87.44% of the spectra observed for runs of the OspA-His and OspAΔS22-His samples, 
respectively.  
 
Discussion 
Here, we used epitope-tagged lipoproteins, determined from previous studies to be 
localized to opposite leaflets of the Borrelia OM, as a starting point in a search for a  
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putative OM translocation channel. Based on data from (Schulze,2009), we 
hypothesized that the mutant OspAΔS22-His protein may be involved in a stalled 
translocation intermediate, perhaps stably interacting with components of a channel 
through which it would normally pass to the cell surface. We used coaffinity 
purification and the sensitive MudPIT analysis to identify proteins potentially 
involved in this transport process..  
 
Certainly, the MudPIT results identify several proteins that are likely to be 
contaminants. BB0151 encodes an N-acetylglucosamine-6-phosphate deacetylase, an 
enzyme that plays a role in cell-wall biosynthesis. It contains several histidine-rich 
regions within its primary sequence, and because it shows up in the negative controls, 
we conclude that this is likely a contaminant. The same can be said for BB0616, a 
hypothetical protein with possible cation efflux pump properties. A close examination 
of its primary sequence reveals a site with the following primary sequence: 
HDHCHSHDHDHDHNHDH. It is therefore likely that the increased presence of this 
protein is due to binding to the cobalt column via this region. BB0615 is likely the 
non-specific band. It has a predicted molecular weight of approximately the same size 
and is present in abundance for all four samples. Unlike BB0151 and BB0616, it does 
not seem to have numerous histidines that might cause it to be pulled down as 
background. It is interesting to note that the ORFs BB0615 (encoding a predicted 
integral membrane protein) and BB0616 (encoding a predicted 30S ribosomal protein) 
are separated by 166 nucleotides on the B. burgdorferi linear chromosome, 
 144 
suggesting that they might actually represent a single gene. Of the remaining proteins 
identified by the MudPIT screen, perhaps the three that deserve the most attention 
going forward are CtpA (BB0359), p66 (BB0603), and the hypothetical lipoprotein 
BB0028.  
 
CtpA is a carboxy-terminal protease known to be closely linked with porin activity in 
Borrelia. It is required for the processing and maturation of the p13 porin and in its 
absence, the Oms28 porin protein is highly upregulated 
(Skare,1996;Noppa,2001;Ostberg,2004). It has also been shown to cleave the 
BB0323 lipoprotein, which we previously localized to the Borrelia IM (Chapter IV). 
Our MudPIT data shows that the subsurface OspAΔS22-His protein but not the surface 
OspA-His protein pulls down CtpA. Examination of Table 2 reveals, however, that 
only a single trypsin fragment was identified in the OspAΔS22-His sample and that 
CtpA is also seen in the non-epitope-tagged samples. Therefore, the associations seen 
here may be artifactual. Still, the close relationship CtpA has with OM porin activity 
in Borrelia must be further investigated. 
 
Analysis of the p66 protein shows that it is a likely porin with the ability to bind to 
β3-chain integrins on the surfaces of mammalian cells 
(Skare,1997;Cugini,2003;Coburn,1999). The adhesin function seems to be misleading 
considering p66 has only very small loops that extend outwards from the surface of 
the cell. Infectious B. burgdorferi contains a “rainforest” of lipoproteins on its 
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exterior that hinder the ability of antibodies from accessing smaller proteins (and 
surface loops like those found on p66) underneath 
(Bunikis,1995;Bunikis,1996;Bunikis,1999). Why a large protein with predicted porin 
activity would primarily act as an adhesin is unknown. An insertional inactivation of 
the BB0603 gene results in decreased channel conductance (approximately 11nS) in 
planar lipid bilayer assays (Pinne,2007). The nature of the substrate for the p66 
channel is unknown. The large conductance is suggestive that the pore is quite large 
in comparison to known E. coli OM porins that have conductances ranging from the 
picosiemens (pS) scale to ~2nS (Benz,1985;Pinne,2007). Could p66 have a role in the 
transport of lipoproteins to the surface? It would be interesting to examine the 
membrane topology of OspA (and other lipoproteins) in the Δp66 strain. Reports 
show that p66 can be pulled-down by formaldehyde cross-linking to OspA 
(Bunikis,1999). Interestingly, p66 is preferentially expressed during mammalian 
infection and is not seen in unfed ticks (Cugini,2003). Though this is the opposite of 
what is known about OspA expression, the finding that p66 might associate with this 
major surface lipoprotein should be further explored. Although our MudPIT data 
shows that p66 only represents 0.85% and 0.44% of the total peptides found in the 
OspA-His and OspAΔS22-His fractions respectively (Table 11), it is not seen in the 
background samples. This indicates specificity of the interaction between OspA and 
p66. 
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BB0028 is a hypothetical lipoprotein of unknown function with homologues found 
only in other species of Borrelia. We previously analyzed the primary sequence of 
this lipoprotein and found that it is predicted to have a shorter N-terminal tether 
(perhaps as short as eight residues, with a sequence of CSSESIFS) than most other B. 
burgdorferi lipoproteins examined (Schulze,2009). Expression levels of the BB0028 
mRNA transcript appear to be greatly elevated during CNS infection of non-human 
primates (Narasimhan,2003) and marginally elevated during growth of Borrelia under 
oxidative stress conditions (Hyde,2006). Aside from these two examples, nothing else 
is known about this lipoprotein. It is noteworthy that BB0028, like p66, specifically 
came down in the epitope-tagged samples but did not appear in the control samples. 
 
In using MudPIT for this analysis, we are making an assumption that a stable 
interaction exists between either the surface OspA-His or subsurface OspAΔS22-His 
protein with a component of a putative transporter. It is altogether feasible that 
mislocalized proteins are freely released into the OMIL and the cause for their 
mislocalization is a result of their inability to properly interact with a translocation 
complex. In such a scenario, the screen we use here would not reveal the nature of the 
transporter. 
 
Regardless, the use of MudPIT for identifying potential OM-translocation complexes 
has demonstrated merit in that it was able to supplement known results (p66) and 
reveal proteins that might otherwise be overlooked (BB0028). It may be 
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disadvantageous, however, due to the sheer volume and complexity of the data it 
returns. One must be careful overinterpreting the results as it is an extremely sensitive 
assay, returning information that could never identified by other screens. In some 
cases, the data resolution is to within a single peptide fragment appearing in the 
spectra. At any rate, fine-tuning and careful control of the input samples may result in 
MudPIT proving to be a useful tool in the study of the OM architecture and protein 
transport mechanisms of B. burgdorferi. The treatment of OspA-His- and OspAΔS22-
His-expressing cells with various crosslinking agents prior to affinity purification 
may reveal additional interesting interactions not observed here.  
 
Materials and Methods 
Strains and Plasmids 
Borrelia burgdorferi strain B313 has been described previously (Schulze,2006), as 
have the following plasmids pRJS0998 (OspAwt), pRJS1203 (OspAΔS22), pRJS1140 
(OspAΔS22-His), and pCSY6a-LinkerHis (OspAwt-His). 
 
Total Protein Prep 
Four 250.0ml cultures of Borrelia burgdorferi strain B313 expressing OspA, OspA-
His, OspAΔS22, or OspAΔS22-His were grown to a density of 5x10
7 spirochetes/ml at 
34°C + 5% CO2. Cells were washed twice with PBS+5mM MgCl2 and then 
resuspended in 20ml lysis buffer (50mM Tris, pH 7.4 / 400mM NaCl / 10mM 
imidazole / 1% n-dodecyl-β-D-maltoside (DDM) / 1mM PMSF). Cells were lysed in 
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a French pressure cell at 14,000psi (two passages/sample) and solubilize with rotation 
at 4°C for one hour. Unbroken cells/debris were removed by spinning samples for 
15min at 10,000g. The supernatant was collected and used for metal affinity 
chromatography. 
 
Metal Affinity Chromatography 
The supernatant was applied to 2ml Talon® Metal Affinity Resin (Clontech) that was 
pre-washed 2x with binding buffer (50mM Tris, pH 7.4 / 400mM NaCl / 10mM 
imidazole / 0.1% DDM / 1mM PMSF). Binding was done for 1h at RT on a rotator. 
The resin was spun down at 700g for 3 min and flow-through was collected. The resin 
washed three times with 20ml binding buffer and resuspended in a final volume of 
2ml binding buffer prior to being transferred to a gravity flow column. The resin was 
allowed to settle and buffer was drained. The column was washed twice with 5ml 
binding buffer (10mM imidazole) and proteins were eluted by treatment with 10ml 
binding buffer containing 20mM imidazole and then 100mM imidazole. 
 
Analysis 
Fractions were concentrated and the buffer was exchanged to Tris-HCl, pH 7.4 using 
an Amicon Ultra-15 centrifugal filter device (3kDa MW-cutoff). The protein 
concentration was determined using Bio-Rad DC protein assay (BSA standard). 
Samples were run on a 12.5% polyacrylamide gel and complexity was visualized by a 
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silver stain. Proteins were precipitated in trichloroacetic acid and submitted for 
MudPIT analysis. 
 
MudPIT 
TCA-precipiated proteins were denatured in 8M urea and treated with 10mM 
iodoacetamide (IAM) and 5mM tris(2-carboxyethyl)phosphine (TCEP) prior to 
overnight incubation with Endoproteinase Lys-C (0.1µg/µl) at 37°C. Samples were 
diluted to 2M urea with 100mM Tris-Hcl, pH 8.5 and CaCl2 was added to 2mM prior 
to overnight trypsinization (0.1µg/µl) at 37°C. Samples were adjusted to 5% formic 
acid.  
 
The tip of a triple-phase fused-silica microcapillary column (100µm i.d. x 365µm o.d. 
fused silica (Polymicro Technologies)) was pulled with a laser puller (Sutter 
Instrument Co. Model P-2000) and packed with 8cm of 5µm C18 reverse-phase 
(Aqua, Phenomenex), 3cm of 5µm strong cation exchange material (Partisphere SCX, 
Whatman), and another 1cm of 5µm C18 reverse phase. The column was washed with 
methanol for 10min and equilibrated in buffer A (5% ACN/0.1% Formic acid) for 
30min. 
 
The digested protein sample was spun down at 14,000rpm for 30min and pressure-
loaded onto the column. The column was washed for 10min in buffer A and placed 
in-line with a LTQ linear ion trap mass spectrometer equipped with an electrospray 
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ionization source. With a flow rate of 200-300nl/min, a 10-step chromatography run 
(20hr) was carried out on the samples in buffer A, buffer B (80% CAN/0.1% formic 
acid), and buffer C (500mM ammonium acetate, 5% ACN, 0.1% formic acid), with 
the last two chromatography steps in a high salt wash with 100% Buffer C followed 
by the acetonitrile gradient to 100% Buffer B. 
 
A 2.5kV voltage was applied distally to electrospray the eluting peptides. Full MS 
spectra were recorded on the peptides over a 400 to 1,600 m/z range, followed by five 
tandem mass (MS/MS) events sequentially generated in a data-dependent manner on 
the first to fifth most intense ions selected from the full MS spectrum (at 35% 
collisional energy). 
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Chapter VI: Discussion 
 
The work presented here represents the very first insights into the process of 
lipoprotein secretion and sorting in Borrelia burgdorferi. We have demonstrated the 
existence of a pathway through which lipoproteins are funneled as they are targeted 
toward the outer surface of the cell. We clearly demonstrate that B. burgdorferi does 
not use the same sorting algorithm used by the Enterobacteriaceae or other Gram-
negatives. Three lipoproteins have been shown by our laboratory (OppAIV, IpLA7, 
and BB0323) to likely reside in the inner membrane. The N-terminal four residues for 
each of these proteins are CVNE (OppAIV), CTSK (IpLA7), and CKTP (BB0323). 
From this data alone we are able to immediately rule out a ‘+2 rule’ based on 
knowledge about three well-characterized surface-localized lipoproteins: 
 
- OspD (CVHD) has a valine at +2 like OppAIV 
- BBA66/p35 (CTID) has a threonine at +2 like IpLA7 (Hughes,2008) 
- OspA (CKQN) has a lysine at +2 like BB0323. 
 
Moreover, the addition of the N-terminal 31 residues of OppAIV to mRFP1 results in 
surface localization of the fluorescent reporter (Schulze,2006). We were able to show 
that negatively-charged residues can act as IM retention signals, but only in an 
appropriate context. We are not at this time able to determine the basis for this 
retention. Because the presence of negatively-charged residues may impact IM 
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release, we suggest that the initial stages of lipoprotein transport may be sequence-
dependent in nature. 
 
We show evidence that surface exposure may be the default pathway for lipoproteins 
in Borrelia, much the same way that the OM is the ‘default’ target of lipoproteins in 
E. coli. We also reveal a possible intriguing role for structural disorder in lipoprotein 
transport. Table 3 (p. 90) suggests that N-terminal disorder may be a phenomenon 
common to lipoproteins of all bacterial phyla. Though the N-termini of B. burgdorferi 
have very little in common sequence-wise, they all seem to have a tendency to be 
made up of residues typically found in unstructured domains. Removal of single 
residues from within this region (Val21-Ser22-Ser-23-Leu24 from OspA, for 
instance) or mutagenesis to prevent structural formation (VSSL  GGGG) all 
negatively impact OM translocation. Interestingly, the addition of an alanine residue 
at an alternative location within the tether was able to rescue the defect seen when 
Leu24 was removed. This suggests a sequence-independent mechanism for transport 
to the cell surface. Are lipoproteins of Borrelia required to adopt a translocation-
competent conformation before they can be transported? What role would flexibility 
play in determining whether a protein might be secreted to the cell surface? These are 
questions that all should be investigated. We identified lp6.6 (BBA62) as a 
lipoprotein which resides in the inner leaflet of the OM (OMIL). A disorder 
prediction run on this peptide using the VSL2B algorithm suggests that it is 
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completely disordered (Schulze, 2009, submitted). Could this be the reason it is 
retained in the OMIL rather than transported to the surface? 
 
With regard to the mechanism of transport between membranes, we know that 
Borrelia has homologues to the LolCDE components as well as a homologue to the 
periplasmic chaperone LolA. Do these proteins function analogously in Borrelia? Are 
the mechanisms of LolCDE avoidance related to interactions of negatively-charged 
side chains with membrane phospholipids (Hara,2003)? Do the LolCDE proteins 
even have the same function in Borrelia? These are questions that may be addressed 
in the near future. We have preliminary evidence that BB0346, the LolA homologue, 
interacts specifically with those lipoproteins that are transported to the surface. Using 
polyclonal antibodes to BB0346 for immunoprecipitation, we show in Fig. 22A that 
only OspA22-, OspA25-, and OspA28-mRFP, all identified in Chapter II to be 
surface-localized constructs, interact with and are co-immunoprecipitated by BB0346.  
 
We think it is likely that Borrelia follows a Lol-like mechanism for IM release and 
periplasmic transport but then follows a different mechanism at the OM. Our model, 
as shown in Fig. 22B, suggests that lipoprotein N-termini are disordered and that this 
condition may be sufficient for transport to the cell surface, provided they are able to 
undergo a transition to a potential translocation-competent state (possibly due to 
binding by a periplasmic chaperone, see Fig. 15, p.88). In the event that this region is 
not stabilized in a correct conformation, then translocation across the OM can be  
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Figure 22.  Role for Borrelia BB0346 and model for transport. (A) We performed 
two immunoprecipitations on whole cell lysates of Borrelia burgdorferi strain B31-e2 
expressing one of five OspA:mRFP1 fusions. C17- and Q19-mRFP1 have been 
previously demonstrated to be localized exclusively to the B. burgdorferi IM 
(Schulze,2006). S22-, D25-, and N28-mRFP1 were previously localized in the same 
reference to the B. burgdorferi cell surface. Here, we show that IP with antibodies 
against mRFP1 shows the presence of each fusion protein in the five strains. IP with 
antibodies against the B. burgdorferi homologue of E. coli LolA (BB0346) reveals 
that only those fusions transported to the surface specifically interact with the putative 
chaperone. (B) A model for lipoprotein transport in Borrelia. At the IM, the presence 
of negatively-charged residues can retain lipoproteins at this step (checkpoint #1). If 
no retention signal is present, the lipoprotein is transported by the BB0346 chaperone 
to an unknown receptor in the OM. Here (checkpoint #2), sequence-independent 
signals such as tether flexibility/conformation may contribute to determining whether 
a lipoprotein is secreted to the cell surface or retained in the inner leaflet of the OM.
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impeded. If, alternatively, sequence-specific signals such as negative charge are 
present in the N-terminus, then release to the BB0346 chaperone from the IM might 
be prevented.  
 
Further examination of the residues that are present at each position may provide 
hints into which residues play regulatory roles in lipoprotein transport. For instance, 
why are aspartic acid residues never found at the +3 position? Why instead are 
leucine residues so common? These types of questions can also be examined for 
lipoproteins of organisms orther than Borrelia. Why are prolines never found at the 
+2/+3 positions of E. coli lipoproteins, for example? See Table 6, p.93 for more 
examples. 
 
In addition to revealing information about the sorting rules of B. burgdorferi 
lipoproteins, we demonstrate the potential advantages to using fluorescent or epitope-
tagged reporters for lipoprotein localization studies. Chapters IV and V detail ways 
we might be able to employ mislocalized lipoproteins to i) identify novel subsurface 
retention signals (through the use of a FACS-based approach) and ii) identify novel 
components of a putative OM translocon (through an affinity co-purification 
approach).  
  
It is possible that the results from these studies will have applications in 
understanding the biology and pathogenesis of other spirochetes, namely Treponema 
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pallidum and Leptospira interrogans. These two pathogens do not have the same 
large number of surface-exposed lipoproteins seen in B. burgdorferi; in fact, many of 
T. pallidum’s lipoproteins are thought to instead be anchored to the cytoplasmic 
membrane (Weigel,1994;Salazar,2002). The genetic intractability of treponemes has 
made it difficult to study lipoprotein biology as it relates to the pathogenesis of the 
organism. Perhaps the heterologous expression of T. pallidum lipoproteins in Borrelia 
would provide exciting new insights into the pathogenesis of the syphilis spirochete. 
Our laboratory has shown previously that surface lipoproteins of relapsing fever 
spirochetes can be displayed on the surface of B. burgdorferi (Zuckert,2004). It is not 
known whether surface transport of lipoproteins is a conserved feature amongst the 
spirochetes. 
 
In summary, the work performed here provides new insights into an unexplored 
system of bacterial protein sorting and transport. Though bacterial lipoprotein 
localization studies have been ongoing for many years, it is quite clear that B. 
burgdorferi uses strikingly different mechanisms to accomplish its task of secreting 
lipoproteins to its cell surface. 
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